System and method for configuring a rule set for medical event management and responses

Abstract
A system and method to configure a rule set used in connection with a medical monitoring system for monitoring patients and patient care equipment, especially medication delivery pumps, based on a variety of conditions and parameters associated with monitored biometric information and equipment information and for providing user-defined responses to those conditions and parameters.
Description
FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

None.


TECHNICAL FIELD

The present invention relates to medical monitoring systems for monitoring hospital patients and patient care equipment based on a variety of parameters and conditions associated with monitored biometric or physiological information and equipment information and for providing user-defined responses to those parameters and conditions.


BACKGROUND AND SUMMARY OF THE INVENTION

Modern medical care often involves the use of medication management systems, which include medication delivery and monitoring devices such as medication delivery pumps and/or patient parameter monitors. Medication management systems for configuring, controlling, and monitoring medication delivery devices have been disclosed. For example, commonly owned U.S. patent application Ser. No. 10/930,358, which published as US20050144043A1 on Jun. 30, 2005 and U.S. patent application Ser. No. 10/783,573, which published as US20050278194A1 on Dec. 15, 2005, disclose a medication management system wherein customizable drug library or medical device configuration information is prepared using a drug library editor (DLE) program and module of a medication management unit (MMU). The MMU downloads the customizable drug library to the medication delivery pump and receives status or activity information from the pump. Commonly owned U.S. patent application Ser. No. 10/783,877, which published as WO2005050526A2 on Jun. 2, 2005, discloses how the drug library or medical device configuration information is created, edited, stored and communicated to a medication delivery device in the context of a medication management system to deliver substances, such as fluids and/or fluid medication to patients.


According to the above-mentioned commonly owned published patent applications, a typical medication management system includes a point of care computer, such as a barcode point of care computer and/or pharmacy computer, and/or an MMU, in communication with one or more medication delivery devices. The point of care computer(s) and/or the MMU, with associated memory, store various information, such as patient information, prescription information, customized drug library or other information, for managing medication delivery to a patients, such as performing five-rights checking, configuring the medication delivery devices, and receiving and storing activity information received from the medication delivery devices.


Caregivers use outputs from patient monitoring and equipment monitoring devices to make various patient care decisions. Patient monitoring devices and patient care equipment monitoring devices may be connected to a receiver, which receives the output signals from the patient monitoring devices and patient care equipment monitoring devices. In some cases, the receivers may display and/or record the information from the patient and patient care equipment monitoring devices. In other cases, the devices may include a monitor and/or recording medium. The receivers or devices may also have preset or adjustable alarms that are triggered when one of the outputs from the patient or patient care equipment monitoring devices deviates from a pre-set limit.


One drawback of such conventional monitoring systems is the occurrence of false positive alarms. Such false positive alarms may occur due to a momentary deviation of a monitored state that deviates from the pre-set limits, but which rapidly returns to a normal state. For example, one application of such a conventional alarm monitoring system is for use in monitoring a patient's reaction to a controlled administration of analgesia. In such systems, currently practiced technologies are subject to the following problems: (1) false alarms due to erroneous respiratory or blood gas readings associated with motion artifacts or poor sensor placement and coupling; and (2) false alarms resulting from patient circumstances in which monitored conditions are not truly indicative of an adverse event. Such an alarm may be triggered, for example, if a patient monitor is briefly disconnected from a monitoring device. False positive alarms waste the time of hospital personnel who need to respond to such alarms. Frequent false positive alarms may also desensitize medical responders to the alarm. In addition, a false positive alarm may cause a medial responder to take improper action believing that the alarm is a true alarm.


Another drawback of such conventional systems is the relative lack of ability to require a response only when there has been a change in multiple monitored parameters, such as a change in blood oxygen levels coupled with a change in breathing. Specifically, for monitoring analgesic application via a pump, alarms are typically associated with univariate parameters, such as SpO2 alone or end tidal CO2 (ETCO2) alone, for detecting changes in these parameters consistent with respiratory depression. These systems are subject to a variety of problems due to the complexity of the body's response to analgesia and the insufficiency of a single variable to represent the range of clinical circumstances and patient parameters that may result from the administration. For example, an undesirable adverse event associated with administration of analgesics, sedatives and anesthetics can be depression of the patient's respiratory and/or central nervous systems. Exacerbating the risk to patients is the profound variation in drug efficacy between patients and through time. Consequently, avoidance of drug overdose is of particular concern to healthcare professionals and can result in the under administration of narcotics. The latter problem leads to unnecessary and significant discomfort and is associated with longer hospital stays and recovery times.


Yet another drawback of such systems is the difficulty of creating a readily customized rule set for monitoring, alarming and requiring responses thereto. Additionally, these systems typically lacked the ability to automatically respond to changes in a plurality of monitored conditions. Furthermore, such traditional systems often lacked the ability to automatically change from a first rule set to a second rule set based on a change in the monitored parameters.


The system disclosed herein is designed to enable hospital personnel to configure a rule set by inputting, via a user-interface, a wide variety of monitored patient or equipment parameters, and conditions associated with those parameters, which, when satisfied by inputs from the medical equipment and patient monitoring devices, trigger a user-defined or user-selected response. The rule set can include Boolean combinations of these parameters and respective conditions to establish a set of multi-variable inputs that must occur before a response is triggered. Authorized hospital personnel can also customize the type of parameter, the conditions for that parameter to be met and type of response for each rule set. The software utilized to implement this invention may use a context free grammar, specifically, Backus-Naur form metasyntax, to build the rule sets comprised of parameters, conditions and responses.


All of the patents and patent application referred to within this Background of the Invention section of the present specification are hereby incorporated by reference and made a part of this specification. In addition, the present invention is provided to solve the problems discussed above and, to provide advantages and aspects not provided by medical systems, as well as achieve other objects not explicitly stated above. A full discussion of the features, advantages and objects of the present invention is deferred to the following detailed description, which proceeds with reference to the accompanying drawings.


Other features and advantages of the invention will be apparent from the following specification taken in conjunction with the following drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

To understand the present invention, it will now be described by way of example, with reference to the accompanying drawings in which:



FIG. 1 is a diagram of one embodiment of a medication delivery device and patient monitoring system of the present invention.



FIG. 2 is a flow chart of one embodiment of a system and method for configuring a rule set for use with a medication delivery device and patient monitoring system of the present invention.



FIG. 3 is a flow chart of a second embodiment of a system and method for configuring a rule set for use with a medication delivery device and patient monitoring system of the present invention.



FIG. 4 is one embodiment of an exemplary interface screen display for configuring a rule set for use with a medication delivery device and patient monitoring system of the present invention.



FIG. 5 is a flow chart of one embodiment of a system and method for selecting a rule set for use with a medication delivery device and patient monitoring system of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

While this invention is susceptible of embodiments in many different forms, there is shown in the drawings and will herein be described in detail preferred embodiments of the invention with the understanding that the present disclosure is to be considered as an exemplification of the principles of the invention and is not intended to limit the broad aspect of the invention to the embodiments illustrated.



FIG. 1 shows an exemplary medical monitoring system for monitoring hospital patients and patient care equipment. As shown in FIG. 1, a medication management system 100 includes a patient monitor 120 for monitoring patient biometric or physiological information of various types. For example, the monitored information can include, but is not limited to, ETCO2, SpO2, respiratory rate, heart rate, blood pressure, temperature and other patient biometric, physiological or medical parameter information. The patient monitor may include appropriate biometric sensors for sensing the desired patient information, as known in the art. Such biometric sensors may include an EKG system, respiratory monitors, blood gas monitors, glucose monitors, blood analyte monitors and/or other measurement systems which monitor a physiological variables or analytes associated with a patient. For example, in the case of a system for patient controlled analgesia (PCA), a NELLCOR or MASSIMO monitor with an ORIDION capnography respiratory monitor board can be used to generate data, waveforms, and alarms associated with heart rates, SpO2 levels, respiratory rates and ETCO2 levels.


The patient monitor 120 can optionally include a processor and patient monitoring application for monitoring the information received by the various biometric sensors. Patient monitor 120 may include a user interface associated therewith to receive input from a patient or caregiver. A patient monitor processor compares the information received from the sensors and generates an alarm signal based on the comparison. Alarm signals can be generated if an alarm limit is met, or alternately when the alarm limit is exceeded. Alarm limits can include an upper limit, a lower limit, or both upper and lower limits that together define one or more acceptable ranges. Patient monitor 120 is communicatively networked with a patient monitor interface and rule set processor 125 for transmitting the monitored information and/or alarms to the patient monitor interface and rule set processor 125.


As shown in FIG. 1, a patient care device, which is shown as a medication delivery pump 130, may be operatively connected to or in communication with the patient. The medication delivery pump 130 may be configured for controlled delivery of a medication to the patient. The medical pump can be used with PCA (patient controlled analgesia) request devices in which a patient can “self-deliver” medication, such as an analgesia or analgesic. For example, U.S. Pat. No. 4,551,133, to Zeggers de Beyl et al., issued Nov. 5, 1985, and incorporated in its entirety herein by reference, discloses a patient controlled analgesia system for introducing medication to a peripheral vein of a patient. The delivery of the analgesic is controlled by a microprocessor based system in response to the patient's requests. Specifically, the microprocessor is associated with a remote patient control or PCA request device, for providing an actuation signal to the microprocessor when the patient requests a delivery of medication.


The system 100 may further have a plurality of medication delivery pumps 130 for the administration of a plurality of medications. The medication delivery pump may further include a user interface that permits a caregiver to provide inputs to the medication delivery pump 130. Such inputs may include a pain score associated with the patient, which may be used to determine the amount and frequency of patient controlled analgesic (PCA) permitted. In one embodiment, the medication delivery pump has a user interface configured to permit a caregiver to select a rule set, herein sometimes referred to as an algorithm, for monitoring the patient and patient care equipment and responding to inputs from the patient and patient care equipment, as described in greater detail below. In addition, the user interface on the medication delivery pump 130 provides a means, such as a push button or a touch screen interface, for a caregiver to respond to an alarm or an infusion event (for example, an infusion pause).


The medication delivery pump 130 is in communication with the patient monitor interface and rule set processor 125 for communicating information between the medication delivery pump 130, the patient monitor interface and rule set processor 125, the patient monitor 120, and other components of the system 100 as described below. As a result, medical pump information can be communicated from the medication delivery pump 130 to other components of the system 100. Such medical pump information may include both medical pump status information and medical event information. Medical pump status information can include but is not limited to whether an active delivery of medication is taking place, the rate of the delivery, volume (delivered or remaining to be delivered) and the length of time passed since the delivery began. Medical pump event information can include but is not limited to whether any alarms or alerts have issued since the last communication, whether an occlusion has taken place, and whether power was lost to the medical pump, among other medical pump event information. Status information and/or medication delivery status information is used herein to refer to at least medical pump status information, medical pump event information, and/or other status and/or event information. The medical delivery status information may be transmitted as historical logs of information or real time communication or information.


The medication delivery pump 130 may also communicate the rule set selected by a caregiver at the medication delivery pump 130 to the patient monitor interface and rule set processor 125. The patient monitor interface and rule set processor 125 is communicatively connected with a central memory 135, which has a library of rule sets or portions thereof stored therein. The library of rule sets can be a part of a customizable drug library or other libraries that can be downloaded to medical devices. In one embodiment, the patient interface and rule set processor 125 applies the selected rule set to the information received from the patient monitor 120, such as ETCO2, SpO2, respiratory rate, heart rate, blood pressure, temperature and other patient parameter information, and/or the information received from the medication delivery pump 130, such as the medical delivery status information, to the rule set. Depending upon whether the conditions and parameters of the rule set are satisfied, the patient interface and rule set processor 125 may generate an output signal to the medication delivery pump 130 that instructs the medication delivery pump to adjust the medication delivery in some manner.


In another embodiment, the patient monitor interface and rule set processor 125 may send information from the patient monitor 120 to the medication delivery pump 130 without processing it through a rule set. The medication delivery pump 130 or the patient monitor 120 may be configured to receive alarm limits inputted by a caregiver. The alarm limits may correspond to the patient information received at the medication delivery pump 130. Alternatively, or additionally, the alarm limits may relate to information regarding the medication delivery pump 130 itself. A pump processor compares the selected alarm limits to the relevant information, and, if the information satisfies (meets, exceeds, falls under or between) the alarm limits, generates an alarm signal from the pump 130. The alarm signal from the pump may be conveyed to the patient monitor and rule set processor 125 and to other components of the system 100 as described below.


The medication delivery pump 130 may display the patient information on a display screen of the medication delivery pump. The display screen may also display a variety of medical pump status information including but not limited to a patient identifier, room number, delivery mode, delivery rate, whether an active delivery of medication is taking place, how long since the delivery began, basal rate, PCA bolus amount, lockout period for the PCA bolus, and lockout volume for the PCA bolus.


In an alternative embodiment that will be easily understood by one skilled in the art in view of the figures and description herein, the patient monitor interface and rule set processor 125 could be a part of either the medication delivery pump 130 or the patient monitor 120 or another component of the system rather than a separate unit. Processing capacity and functions can be distributed among the components of the system 100 as shown and described or they can be rearranged and/or combined within any of the other processors in the system.


The central memory 135 is in communication with a rule set configuration processor 140. The rule set configuration processor 140, which may be a personal computer, personal digital assistant (PDA) or the like, has a user input that permits an administrator to create and configure a rule set, sometimes referred to herein as an algorithm, as described in greater detail below. The rule set is then sent to and stored in the central memory 135.


The central memory 135 also may receive certain information from the patient monitor interface and rule set processor 125. Specifically, the central memory 135 may receive logs of the patient information generated by the patient monitor 120 and the medication delivery pump information generated by the medication delivery pump 130. This information may also be sent to the central memory 135 from the patient monitor interface and rule set processor 125 in real time.


The central memory 135 may also store information related to the patient's medical history and recent medical treatments, and, in particular, the patient's recent history of infused medication. This information may be accessed by the patient monitor interface and rule set processor 125 or any other component of the system 100 when such information is required as an input for processing a rule set. For example, a rule set may require inputs regarding the amount of a drug still active in the patient, which could be determined based on the amount of the drug that the patient has received and how recently the drug was delivered to the patient, which would be stored in the central memory 135. A detailed example of such a rule set is described below.


The central memory 135 may also receive outputs from the patient monitor interface and rule set processor 125 that are generated as a response to processing inputs via a rule set. Specifically, if the parameters and associated conditions of a certain rule set are satisfied, the patient monitor interface and rule set processor 125 may send an alarm instruction to the central memory 135, which may then be sent to a caregiver, as described below. In another example, if the parameters and conditions of a rule set are satisfied, the patient monitor interface and rule set processor 125 may send a signal to the central memory 135 to access a different rule set stored in the central memory 135.


The central memory 135 may further distribute the information that it receives from the patient monitor interface and rule set processor 125 to a reports server 145, a central monitor 150 and a remote notification server 155. In particular, the reports server 145 may receive summaries, overviews and logs of the medication delivery pump information and the patient monitor information for generating reports that can be sent to or made available to administrators. The central monitor 150 may receive similar information for displaying information from the medication delivery pump 130 and patient monitor 120 and provide this information to a caregiver at a location remote from the patient. The remote notification server 155 will typically receive instructions to notify caregivers of certain changes in patient or equipment status. For example, if the parameters and conditions of a rule set are satisfied and the rule set dictates that a caregiver should be notified in such an event, the remote notification server 155 will generate a notification to the caregiver. Such notifications may be conveyed to one or more small personal digital assistant computers including but not limited to a pager, cell phone or PDA that is in communication with the remote notification server 155. The small digital assistant computers can be carried by the caregivers and used by them to identify themselves through the use of built in barcode scanners or otherwise as they perform certain caregiving functions, such as performing scheduled rounds in which the caregivers deliver medication to patients in patient rooms within a caregiving facility.


In an alternative embodiment, the reports server 145, central monitor 150 and remote notification server 155, or any combination of these devices may be networked directly to the patient monitor interface and rule set processor 125, the pump 130 and/or the patient monitor 120.


Communication of information between the various components of the system may occur in a variety of ways. Information may be communicated between the various devices in a real-time constant stream, the information may be pushed from the sending to device to the receiving device on a periodic basis or on a continuous loop, the information may be pulled from the sending device by the receiving device on a periodic basis or on a continuous loop, and/or the various devices may be configured to push or pull the information based on various triggering events, for example, the passage of time or once a certain amount of information has been accumulated. The components of the system shown in FIG. 1 are described in greater detail below.


The medication delivery pump or medical pump 130 includes but is not limited to enteral pumps, infusion pumps, cassette pumps, syringe pumps, peristaltic pumps, or any fluid pumping device for the delivery of fluids intravenously, intra-arterially or otherwise to a patient. A pump processing unit or pump processor may be included in pump 130 and performs various operations, as described in greater detail herein. An input/output device or user interface communicates with the pump processing unit and allows the user to receive output from pump processing unit and/or input information or commands into the pump processing unit. Those of ordinary skill in the art will appreciate that input/output device may be provided as a separate display device and/or a separate input device. For example, in one embodiment of the present invention, the medical pump 130 includes a patient-controlled analgesia (PCA) request device which is in electrical communication with the processor, for receiving an input from a person to generate a medication request signal from the PCA request device.


A pump memory communicates with the pump processor and stores code and data necessary for the pump processor to calculate and output the operating parameters of the pump 130. The pump memory stores a programming code, such as a medication delivery programming code or application for processing data to determine and control the operating parameters of the medical pump 130.


With continued reference to FIG. 1, the medical pump 130 can also include a communications engine or interface, in electrical communication with the pump processor, for transmitting/receiving communications between the pump processor, the patient parameter monitor 120, and the patient monitor interface and rule set processor 125, as described in detail herein. In fact, in one embodiment where the rule set processing function is integrated into the pump 130, the communication engine also serves as the patient monitor interface.


The central memory 135 can include a central programming code, such as a central medication management application and/or central patient monitoring application and other applications, for execution by the central processor, which can perform various medication management, patient monitoring, and other functions, as described in greater detail herein. Further, the medical pump 130 can include many aspects of a LifeCare PCA® Infusion System, and the medication management application within the central memory 135 can include many aspects of Hospira MedNet® Software, both manufactured and sold by Hospira, Inc., the assignee of the present invention, in conjunction with the present invention.


Generally, in terms of hardware architecture, as shown in FIG. 1, the medical pumps 130, patient parameter monitors 120, patient monitor interface and rule set processor 125, rule set configuration processor 140, central monitor 135, reports server 145, and remote notification server 155 of the medication management and/or patient parameter monitoring systems 100, may each include a processor, memory, and one or more input and/or output (I/O) devices (or peripherals) that are communicatively coupled via a local interface. The local interface can be, for example, but not limited to, one or more buses or other wired or wireless connections, as is known in the art. The local interface may have additional elements, such as cables, controllers, buffers (caches), drivers, repeaters, and receivers, to enable communications. Further, the local interface may include address, control, and/or data connections to enable appropriate communications among the other computer components.


The processors are hardware devices for executing software, particularly software stored in memory. The processors can be any custom made or commercially available processor, a central processing unit (CPU), an auxiliary processor among several processors associated with the medical pumps 130, patient parameter monitors 120, patient monitor interface and rule set processor 125, rule set configuration processor 140, central monitor 150, reports server 145 and remote notification server 155 of the medication management and/or patient parameter monitoring system 100, a semiconductor based microprocessor (in the form of a microchip or chip set), a macroprocessor, or generally any device for executing software instructions. Examples of suitable commercially available microprocessors are as follows: a PA-RISC series microprocessor from Hewlett-Packard Company, an 80x86 or Pentium series microprocessor from Intel Corporation, a PowerPC microprocessor from IBM, a Sparc microprocessor from Sun Microsystems, Inc., or a 68xxx series microprocessor from Motorola Corporation. The processors may also represent a distributed processing architecture such as, but not limited to, EJB, CORBA, and DCOM. In one embodiment, the central memory 135 and reports server 145 is on a WINDOWS based server or series of servers.


Each memory of each of the medical pumps 130, patient parameter monitors 120, patient monitor interface and rule set processor 125, rule set configuration processor 140, central monitor 150, reports server 145 and remote notification server 155 of the medication management and/or patient parameter monitoring systems 100, can include any one or a combination of volatile memory elements (e.g., random access memory (RAM, such as DRAM, SRAM, SDRAM, etc.)) and nonvolatile memory elements (e.g., ROM, hard drive, tape, CDROM, etc.). Moreover, these memories may incorporate electronic, magnetic, optical, and/or other types of storage media. The memories can have a distributed architecture where various components are situated remote from one another, but are still accessed by the processors of the medical pumps 130, patient parameter monitors 120, patient monitor interface and rule set processor 125, rule set configuration processor 140, central monitor 150, reports server 145, and remote notification server 155 of the medication management and/or patient parameter monitoring system 100.


The software within one or more of the above referenced memories may include one or more separate programs. The separate programs comprise ordered listings of executable instructions for implementing logical functions. In the examples of FIG. 1, the software in the memories can include suitable operating systems (O/S). A non-exhaustive list of examples of suitable commercially available operating systems for at least some of these devices is as follows: (a) a WINDOWS operating system available from Microsoft Corporation; (b) a NETWARE operating system available from Novell, Inc.; (c) a MACINTOSH operating system available from Apple Computer, Inc.; (d) a UNIX operating system, which is available for purchase from many vendors, such as the Hewlett-Packard Company, Sun Microsystems, Inc., and AT&T Corporation; (e) a LINUX operating system, which is freeware that is readily available on the Internet; or (f) a run time VXWORKS operating system from WindRiver Systems, Inc. The operating systems essentially control the execution of other computer programs, such as the medication delivery applications, network interface applications, patient monitoring applications, central medication management applications, central patient monitoring applications, and/or biometric applications, in accordance with the present invention, and provide scheduling, input-output control, file and data management, memory management, and communication control and related services.


The I/O devices referred to above may include input devices, for example input modules for PLCs, a keyboard, mouse, scanner, microphone, touch screens, interfaces for various medical devices, bar code readers, biometric receivers, PCA request devices, stylus, laser readers, radio-frequency device readers, etc. Furthermore, the I/O devices may also include output devices, for example but not limited to, output modules for PLCs, a printer, bar code printers, displays, etc. Finally, the I/O devices may further include devices that communicate both inputs and outputs, for instance but not limited to, a modulator/demodulator (modem; for accessing another device, system, or network), a radio frequency (RF) or other transceiver, a telephonic interface, a bridge, and a router.


If the medical pumps 130, patient parameter monitors 120, patient monitor interface and rule set processor 125, rule set configuration processor 140, central monitor 150, reports server 145, and remote notification server 155 of the medication management and/or patient parameter monitoring system 100 are a PC, workstation, PDA, or the like, the software in the respective memories may further include a basic input output system (BIOS) (not shown in FIGS. 1, 2 and 3). The BIOS is a set of essential software routines that initialize and test hardware at startup, start the O/S, and support the transfer of data among the hardware devices. The BIOS is stored in ROM so that the BIOS can be executed when the medical pumps 130, patient parameter monitors 120, patient monitor interface and rule set processor 125, rule set configuration processor 140, central monitor 150, reports server 145, and remote notification server 155 of the medication management and/or patient parameter monitoring system 100 are activated.


When the medical pumps 120, patient parameter monitors 130, patient monitor interface and rule set processor 125, rule set configuration processor 140, central monitor 150, reports server 145, and remote notification server 155 of the medication management and/or patient parameter monitoring system 100, are in operation, the processors therein are configured to execute software stored within respective memories, to communicate data to and from memories, and to generally control operations of the components of the medication management and/or patient parameter monitoring system 100, pursuant to the software. The medication delivery applications, network interface applications, patient monitoring applications, central medication management applications, central patient monitoring applications, and/or biometric applications, and the O/S, in whole or in part, but typically the latter, are read by respective processors, perhaps buffered within the processors, and then executed.


When the medication management and/or patient parameter monitoring system 100 is implemented in software, as is shown in FIG. 1, it should be noted that the application programs therein can be stored on any computer readable medium for use by or in connection with any computer related system or method. In the context of this document, a computer readable medium is an electronic, magnetic, optical, or other physical device or means that can contain or store a computer program for use by or in connection with a computer related system or method. In the context of this document, a “computer-readable medium” can be any means that can store, communicate, propagate, or transport the program for use by or in connection with the instruction execution system, apparatus, or device. The computer readable medium can be for example, but not limited to, an electronic, magnetic, optical, electromagnetic, infrared, or semiconductor system, apparatus, device, or propagation medium. More specific examples (a non-exhaustive list) of the computer-readable medium would include the following: an electrical connection (electronic) having one or more wires, a portable computer diskette (magnetic), a random access memory (RAM) (electronic), a read-only memory (ROM) (electronic), an erasable programmable read-only memory (EPROM, EEPROM, or Flash memory) (electronic), an optical fiber (optical), and a portable compact disc read-only memory (CDROM) (optical). Note that the computer-readable medium could even be paper or another suitable medium upon which the program is printed, as the program can be electronically captured, via, for instance, optical scanning of the paper or other medium, then compiled, interpreted or otherwise processed in a suitable manner if necessary, and then stored in a computer memory.


As referenced above, an administrator, also referred to herein as an authorized user, may configure a rule set for use with the system 100 at a rule set configuration processor 140. A rule set includes one or more parameters, for example patient physiological or biometric parameters, which may have conditions associated with the respective parameters, and one or more responses.


Methods of creating, establishing, or receiving a rule set configuration 200 and 300 are shown in FIGS. 2 and 3, respectively and understood in view of FIG. 1. The rule set configuration processor 140 receives an instruction from the administrator to set up a new rule set at steps 205, 305. The rule set configuration processor 140 then receives a rule set name entered or selected by the user, for example “Pediatric” or “Sleep Apnea” at steps 210, 310. The rule set configuration processor 140 then receives a first medical system parameter entered by the user at steps 215, 315. The parameters may be associated with one of the types of information received by the patient monitor from the biometric sensors, such as the ETCO2, SpO2, respiratory rate or heart rate. The parameters may also relate to an alarm received from the patient monitor 120, for example, a “low blood pressure” alarm. The parameters could also relate to information received from the medication delivery pump 130 or an alarm from the medication delivery pump. After receipt of the medical parameter, a condition associated with that medical parameter and inputted by the authorized user is received. As shown at steps 220 and 225, where the parameter relates to a numerical value rather than a binary event, the condition may be comprised of a first medical condition operator, for example “>”, “<”, “=”, or “≠” followed by a first medical condition value. As shown in FIG. 3 in step 320, when the medical parameter relates to a binary event, such as an alarm, after receipt of the medical parameter, the condition may be a simple binary state related to the parameter, such as “occurs” (“occurred”) or “does not occur” (“has not occurred”). However, such conditions may, in some cases, have additional limitations, such as “occurs and persists for 30 seconds.” Various possibilities come to mind in view of these examples in the context of the present specification.


As shown at steps 230, 325, the rule set configuration processor 140 is configured to optionally receive additional parameters, condition operators and/or condition values. If the administrator opts to enter additional parameters, conditions, and/or condition values, the administrator enters, and the rule set configuration processor 140 receives, a Boolean operator, for example including but not limited to AND, OR, NOT, etc. for connecting the multiple parameters, conditions, and/or condition values shown at steps 235, 330 and optionally additional parameters, conditions, and/or condition values as shown at steps 240, 245, 315, 320. As can be understood in view of FIGS. 3 and 4, one example of the second parameter/condition/value could be that a SpO2 alarm occurs and persists for five minutes. One skilled in the art will recognize that this latter complex type of parameter/condition/value state can itself be expressed or comprised of two separate, simpler states connected by a Boolean operator. For example, the first state can be expressed simply as a SpO2 alarm occurs and the second state can be expressed as a SpO2 alarm has persisted for more than five minutes. The two states can be connected by the Boolean operator AND. Alternatively, such complex states can be expressed through use of an optional decision block and loop through the conditions and/or values within the parameter of interest. States can be expressed in a variety of ways including but not limited to that a condition occurs X times in Y seconds or for X of the last Y seconds. Other units of time such as minutes or hours could be selected by the user to configure the rule set.


Once all of the parameters have been received, the rule set configuration processor 140 is configured to receive a first medical system response, as shown at steps 250, 335, entered by the administrator. The medical system responses may include the generation of an update to a central monitoring system, generation of a prompt to a caregiver requiring input from the caregiver, or an automated adjustment of a patient care device. For example, one such response might be to send a message to the caregiver suggesting an alternate form of treatments. Another such response is to send a signal to the medication delivery pump instructing it to pause an infusion or modify the rate of infusion, for example by decreasing it. Yet another response can include a call to the central memory to retrieve a different, previously entered, rule set and to implement that different rule set. The call can be based on the name of the different rule set that has previously been created and stored, and therefore has a name to use to refer to it within the call process. As shown in steps 255, 260, and 335, 340, a user may enter a plurality of responses. Once all conditions and responses have been received by the rule set configuration processor 140, the configuration process is complete and the rule set is then saved at steps 265, 345.


Flexibility in permitting authorized users to configure rule sets that incorporate a variety of parameters, conditions and responses can be achieved by using a context free grammar such as a Backus Naur Format (BNF) code. A partial listing of an exemplary BNF code for building the rule sets is listed in Appendix A, hereto.


In the exemplary grammar in Appendix A, variables, which are referred to herein as non-terminal symbols are shown in angled brackets < and >. (It should be noted that use of the <conditions> symbol in the exemplary grammar in Appendix A is not intended to have the same meaning as the term “conditions” as used within other portions of the specification.) Each non-terminal symbol can be comprised of a number of alternatives. The alternatives for the non-terminal symbol are listed after the ::= sign and each alternative is separated by the | symbol. The alternatives may themselves be non-terminal symbols or they may be terminal symbols that are shown in quotes. The alternatives may also comprise both a non-terminal portion and a terminal portion. For the convenient reference, the convention of indicating non-terminal symbols in angled brackets and terminal symbols in quotes is used in the description herein. The exemplary grammar for constructing a rule is further described below.


The grammar in the example shown provides for an alarm integration algorithm that includes at least one algorithm name, one or more conditions, and one or more do statements that include one or more responses. The algorithm name, the conditions symbol and the responses symbol are all non-terminal symbols (as indicated in the grammar above by the fact that these terms are provided in angled brackets < and >) that can be satisfied by a plurality of alternatives that are provided for each of these non-terminal symbols. For the <algorithm name> symbol, the alternatives comprise a bracketed string of characters, which is a string of characters surrounded by square brackets [ ]. The <condition> symbol may be satisfied by a single condition alternative or more than one condition alternative. For the <condition> symbol, the condition symbol alternatives comprise alarm and equipment parameters and associated conditions. These condition symbol alternatives may have one or more non-terminal symbols. For example, the condition symbol alternatives in the above-described grammar have the non-terminal symbols <alarm>, <count>, <duration> and <device>. Alternatively, some of the condition alternatives may be terminal. For example, one such terminal parameter satisfying the <condition> symbol may be “power is lost.” The <alarm> symbol may be satisfied by either the entry of an <alarm-type>, which is non-terminal, followed by the text “alarm” or by the entry of an <alarm-type> followed by the text “alarm from” followed by a <device>. The <alarm-type> alternatives are all terminal alternatives, which are text entries as shown in the above grammar. The <alarm-type> alternatives may indicate the type of the alarm, e.g. “LOW_RESP_RATE” would indicate a low respiratory rate alarm.


The <count> symbol is satisfied by the alternatives “1 time” or <between-2-and-100> “times.” The <between-2-and-100> times symbol is satisfied by the integers “2” through “100”. The <duration> symbol is satisfied by a number of non-terminal symbols including <seconds>, <minutes>, <hours>, <minutes> <seconds>, <hours> <minutes> or <hours> <minutes> <seconds>. The <hours> symbol is satisfied by either “1 hour” or <between-2-and-24> followed by “hours” where <between-2-and-24> is satisfied by the integers “2” to “24”. The <minutes> symbol is satisfied by the alternatives “1 minute” or <between-2-and-59> followed by “minutes” where <between-2-and-59> is satisfied by the integers “2” to “59”. The <seconds> symbol is satisfied by either “1 second” or <between-2-and-59> followed by “seconds”.


The <device> symbol is satisfied by the symbol <device-manufacturer> followed by <device-model>, where both <device-manufacturer> and <device-model> are satisfied by bracketed strings.


The <responses> symbol is satisfied by either the <response> symbol or a <response> followed by a comma and the <responses> symbol, thereby enabling the <response> symbol to comprise either a single response or more than one response. The <response> symbol is satisfied by a plurality of response alternatives, which can include both terminal symbols and non-terminal symbols. As shown in the exemplary grammar, the response alternatives may include terminal symbol instructions such as an instruction to update the central monitor, an issuance of a remote notification, a decreasing of the infusion rate of a pump by a set percentage or a pausing of an infusion. Non-terminal symbols may include the response alternative of switching to <algorithm-name>, which would enable the response alternative of switching to another algorithm. As described above, the <algorithm-name> is comprised of a bracketed string of characters. Alternatively, some of the terminal responses described above could be structured as non-terminal responses. For example, the responses relating to decreasing the infusion rate could be structured as “DECREASE_INFUSION_RATE_BY” <percentage-change> “percent” where <percentage-change> is satisfied by the integers “1” to “99”.


An interface for creating rule sets is shown in FIG. 4 as 500. A first field 502, shown as the “Name” field, is provided for receiving entry of the medical delivery system rule set name. A second field 504, shown as the “Parameters” field, is provided for receiving a selection of a parameter and an associated condition, for example, “High ETCO2 alarm occurs.” Function buttons, 506, 508, 510, 512 are provided for receiving an input from a user to add, delete, modify or group the parameters and conditions. A third field 514, shown as the “Responses” field, is provided for receiving an authorized user's selection of the desired responses. As shown in FIG. 4, the responses may include updating a central monitor, issuing a remote notification to a caregiver, adjusting the infusion rate of a medication delivery pump, and/or switching to an alternative or different rule set.


In another aspect of the invention, once an authorized user has constructed the rule set and stored that rule set on the rule set configuration processor 140 and/or the central memory 135, the rule set may be selected by a caregiver and used to monitor the patient and patient care equipment system 100. The rule sets may be cataloged, grouped, or cross-referenced in the central storage in a variety of ways, including but not limited to by patient type (for example, an adult versus a pediatric patient), drug name (for example, morphine) or drug type (for example, opiate, narcotic, antibiotic, or cardiac), or location or ward within the care facility, which is sometimes referred to as a clinical care area (CCA), (for example, intensive care unit or ICU versus Emergency). For example, the rule sets may be organized, named, or entitled by patient parameter, e.g. “Sleep Apnea,”; patient characteristic, e.g. “Pediatric”; monitored variables; infused drugs; estimated patient drug sensitivity based upon infusion history and patient age, weight, etc.; and/or history of invalid infusion pump alarms and/or actions.


As shown in FIG. 5, via any of the processors in the system 100 either the medical delivery pump 130 or the patient monitor 120, or both, can receive alarm limit selections input by a caregiver in step 605. As shown in step 610, the medical delivery pump input receives a particular group of rule sets, such as a particular clinical care area or all CCAs, based upon a selection input by the caregiver. In step 615, the processor 125 then accesses a database of rule sets stored on the central memory 135 that are correlated to the selection of the caregiver. In step 620, the caregiver selects the appropriate rule set; or, if only one rule set is returned, that rule set is implemented. In step 625, the patient monitor 120, and optionally the pump 130, receives the patient physiological information from the biometric sensors. The patient monitor and/or pump processor(s) compare the received physiological information, and if the alarm limits are exceeded, generate an alarm signal, which is sent to the patient monitor interface and rule set processor 125 as shown in step 630. The alarms and/or the physiological data and/or the monitored equipment data are processed according to the rule set as shown in step 635. If the rule set parameters and conditions are met, the patient monitor interface and rule set processor 125 outputs (or executes, in the case of an alternative or different rule set) the designated response or responses in step 640.


An example of a rule set configured to implement a series of new or different rule sets follows. In the case of PCA monitoring, three rule sets may be provided which respond to alarms associated with a patient's respiratory rate and ETCO2 level. The first rule includes the parameter that one of the two alarms must be active for a minimum of 30 seconds prior to an action (e.g., pausing drug infusion). The second rule has a more restrictive parameter in which both alarms must be active for a minimum of 30 seconds prior to an action. The third rule defines the parameter for an infusion pause as an active ETCO2 alarm for more than thirty seconds.


Although the clinician begins the PCA program using the first rule set, generation of two successive invalid pause events will lead to a change to the second rule at the time the second event is identified as invalid. This change could be automatic, in the case where the response specifies that the rule set be switched, or it could merely be suggested in the case where the rule set is configured to suggest to the caregiver that he or she switch rule sets. Similarly, if the two or more successive alarms are associated with only respiratory rate, the rule set could suggest through the pump interface that the clinician enable the third rule set. In this manner a series of rules sets are linked providing greater or lesser sensitivity to externally generated alarms. Suggestions for shifts between rule sets or changes to existing rule sets could also be generated to system administrators based on information acquired during the operation of the system.


An example of an application of a rule set in which a patient's recorded history of infusion events is used as a condition follows. To detect the potential for respiratory distress, a patient's respiratory rate and ETCO2 are assessed using a respiratory monitor and a caregiver sets limits to 3-60 breaths per minute or bpm and 8-60 mmHg respectively, beyond which an alarm will be produced. With the respiratory monitor configured, the rule set is implemented within one of the processors described herein to reduce the number of false positives by requiring an alarm to be present for a minimum of 30 seconds AND within N time constants of a bolus infusion of the medication associated with respiratory distress. In this context, N is generally set to one (1) but can be modified depending upon the patient's age, disease status, co-morbidities and/or other constraints. For example, in the case of morphine delivery to a patient with liver disease, the standard time constant related to drug action is increased due to the lower metabolizing of the liver. The time constant is set to a default value associated with each drug.


Alternately, a status variable can be defined representing the patient drug load. The status variable can be used, in conjunction with individual alarms and a probability function, to improve the detection of a drug-induced adverse event and more specifically, respiratory depression. The drug load is estimated through the relationship:

Drug Load=Background Infusion+Summation (Bolus Dose*(time since dose)/(drug half-life))


Alternately, a first-order approximation for the pharmacokinetic drug elimination is:

Drug Load=Background Infusion+Summation (Bolus Dose*exp(—(time since dose)*(elimination rate constant)))


Where the elimination rate constant is estimated by the ln(2)/(half life).


In the simplest case, the function is a pre-set limit common to the particular drug. However, alternate functions can be used as well, including a percentage increase over time, a percentage increase over a pre-set limit, a sudden change in the rate of drug load, or other constraints. As a further alternative, fuzzy logic may be used to map the drug load to “high” or “low” and thereby qualify the output of the second alarm system as “probable” or “improbable”. In the former situation, a rule set can be configured to create an alarm to a caregiver and to pause the delivery pump. In the latter situation, the rule set may be configured to only send an alarm to the caregiver.


In a further alternative, the drug load can be estimated as the mean drug consumption (MDC) over a period of time and used with the probability measures provided above.


In yet another example, the grammar disclosed above can be combined with both a drug infusion history for estimating the current patient drug load and the history of drug infusion requests. In particular, the demand to delivery ratio (D/D) and mean drug consumption (MDC) may be used as parameters in a rule set. A low MDC suggests alarms indicative of respiratory depression are likely invalid. However, when MDC is high, the D/D ratio is used to further qualify the drug infusion. When MDC is within 80% of maximum and D/D ratio is low (<1), the probability of a valid alarm event is likely. However, when the D/D ratio is high (>2), an indicator is provided suggesting the current pain medication is ineffective and therefore leading to high infusion rates and respiratory depression. Thus, both the calculated MDC and D/D ratio may be used in connection with respiratory rate as conditions in the rule set to provide further discrimination and decision support.


As mentioned herein, a response within a rule set can suggest or “recommend” to a caregiver to take certain actions related to the rule set and the parameters and conditions therein. For example, if a patient has not requested a PCA bolus for a twelve (12) hour period of time, the present system and method can be configured to allow an administrator or caregiver to configure a rule set to recommend to “change the therapy”. Thus, the parameter that the administrator or caregiver could select would be “PCA Bolus Requests”. The condition that the administrator or caregiver could select would be “None in 12 Hours”. Alternative configurations could include the parameter being “No PCA Bolus Requests” and the condition being “In 12 Hours”. Likewise, the response that the administrator or caregiver could select would be “Suggestion—Change Therapy [In View Of No PCA Bolus Requests In 12 Hours]”. Other examples come to mind in view of the present example and description. The caregiver may either respond on their own accord or based on the system-generated suggestion respond by reduce the basal rate of infusion or wean the patient off of PCA therapy.


In another example, if a patient's pain scores are high (e.g., greater than 8 on a 10 point scale) and the patient PCA requests are frequent (e.g. more than ten (10) PCA denied events in a 4 hour period) then the present system and method can be configured to allow an administrator or caregiver to configure a rule set to recommend to “change the medication”. Thus, the parameters that the administrator or caregiver could select would be “Average of Pain Scores” and “Denied PCA Bolus Requests”. The Boolean operator that the administrator or caregiver could select would be an “AND” between the two parameters. The conditions the caregiver would select are “greater than 8” for the “Average Pain Scores” parameter and “More than ten (10) PCA denied events in four (4) hours” for the “Denied PCA Bolus Requests” parameter. Alternative configurations are possible. The response that the administrator or caregiver could select would be “Suggestion—Change Medication”. Other examples come to mind in view of the present example and description. The caregiver may then, either on their own accord or based on the system-generated suggestion, respond by changing the medication. “Changing medication” can involve any one or a combination of the following: changing the program of the pump 130, changing to a different drug, or changing to a different drug concentration.


Any process descriptions or blocks in figures represented in the figures should be understood as representing modules, segments, or portions of code which include one or more executable instructions for implementing specific logical functions or steps in the process, and alternate implementations are included within the scope of the embodiments of the present invention in which functions may be executed out of order from that shown or discussed, including substantially concurrently or in reverse order, depending on the functionality involved, as would be understood by those having ordinary skill in the art.


Because of the interconnection of the various processors within the system 100, rule sets can be created or selected in a variety of locations within the system. By way of example and not limitation, rule sets can be created, modified, and saved at any processor in the system that has sufficient processing capability and access to memory for storage. By way of example and not limitation, rule sets can be selected on the patient monitor 120, on the pump or medication delivery device 130, on the patient monitor interface and rule set processor 125 or any combination thereof. The patient monitor interface and rule set processor 125 can be a communications engine located on the pump 130, on the patient monitor 120, on a separate module or shared between such components.


While the specific embodiments have been illustrated and described, numerous modifications come to mind without significantly departing from the invention. The scope of protection is only limited by the scope of the accompanying claims.












Appendix A















 <alarm-integration-algorithm>


  <algorithm-name>


  “is defined as when”


  <conditions>


  “do (” <responses> “)”


 <algorithm-name> :: = <bracketed-string>


 <conditions>


  “(” <condition> “)” |


  “(” <conditions> “)” |


  <conditions> <boolean> <conditions>


 <condition> :: =


  <alarm> “occurs” |


  <alarm> “occurs” <count> “within a period of” <duration> |


  <alarm> “occurs and is not reset or cleared within” <duration> |


  <alarm> “does not occur for at least” |


  <duration> |


  “communication with” <device> “is lost” |


  “communication with” <device> “is restored”


 <alarm> :: =


  <alarm-type> “alarm” |


  <alarm-type> “alarm from” <device>


 <alarm-type> :: =


  “NO_BREATH” |


  “HIGH_ETCO2” |


  “LOW_ETCO2” |


  “HIGH_RESP_RATE” |


  “LOW_RESP_RATE” |


  “HI_FICO2” |


  “NO_PULSE” |


  “HIGH_PULSE_RATE” |


  “LOW_PULSE_RATE” |


  “LOW_SPO2” |


  “SPO2_SENSOR_OFF_PATIENT” |


  “SPO2_SENSOR_DISCONNECTED”


 <device> :: =


  <device-manufacturer> <device-model>


 <device-manufacturer> :: =


  <bracketed-string>


 <device-model> :: =


  <bracketed-string>


 <responses> :: =


  <response> |


  <response> “,” <responses>


 <response> :: =


  “UPDATE_CENTRAL_MONITOR” |


  “ISSUE REMOTE_NOTIFICATION” |


  “DECREASE_INFUSION_RATE_BY_25%” |


  “DECREASE_INFUSION_RATE_BY_50%” |


  “DECREASE_INFUSIONCRATE_BY_75%” |


  “PAUSE_INFUSION” |


  “SWITCH_ALGORITHM_TO” <algorithm-name>


 <boolean> :: =


  “and” | “or”


 <bracketed-string> :: =


  “[” <string> “]”


 <string> :: =


  <char> |


  <char> <string>


 <char> :: =


  <letter> |


  <digit> |


  <space>


 <letter> :: =


  “a” | “b” | ... | “z” |


  “A” | “B” | ... | “Z”


 <digit> :: =


  “0” | “1” | ... | “9”


 <space> :: =


  “ ”


 <count> :: =


  “1 time” |


  <between-2-and-100> “times”


 <duration> :: =


  <hours> <minutes> <seconds> |


  <hours> <minutes> |


  <hours> <seconds> |


  <minutes> <seconds> |


  <hours> |


  <minutes> |


  <seconds>


 <hours>:: =


  “1 hour” |


  <between-2-and-24> “hours”


 <minutes> :: =


  “1 minute” |


  <between-2-and-59> “minutes”


 <seconds> :: =


  “1 second” |


  <between-2-and-59> “seconds”


 <between-2-and-100> ::= “2” | “3” | ... | “100”


<between-2-and-59> ::= “2” | “3” | ... | “59”










One exemplary simple rule according to the grammar is listed below.














[Simple rule set]


 is defined as when


  (HIGH_ETCO2 alarm occurs)


 do


  (PAUSE_INFUSION)










Another such more complicated exemplary rule set that has several parameters as well as several responses according to the grammar listed below.














[More complicated rule set with multiple responses]


 is defined as when


  (


   (


    (HIGH_ETCO2 alarm occurs) or


    (LOW_RESP_RATE alarm occurs) or


    (LOW_SPO2 alarm occurs and is not reset or


    cleared within 5 minutes)


   )


   or


   (communication with patient monitor is lost)


  )


 do


  (


   PAUSE_INFUSION,


   ISSUE_REMOTE_NOTIFICATION,


   UPDATE_CENTRAL_MONITOR


 )








Claims
  • 1. A method for implementing a medical system algorithm by an authorized medical caregiver, the method comprising: receiving a condition of a parameter associated with one or more sensors configured to measure the parameter of the patient;receiving a selection of a customizable algorithm from a plurality of customizable algorithms, each of the plurality of customizable algorithms comprising a predetermined response, the predetermined response being associated with a preselected parameter and a preselected condition of the preselected parameter, wherein the plurality of customizable algorithms comprise non-terminal parameter symbols and terminal parameter symbols that are configured to be satisfied by a plurality of non-terminal medical device parameters and terminal medical device parameters, non-terminal condition symbols and terminal condition symbols that are configured to be satisfied by a plurality of nonterminal medical device conditions and terminal medical device conditions, and a response symbol that is configured to be satisfied by a plurality of medical system responses;comparing the received condition of the parameter with the preselected condition of the preselected parameter associated with the selected customizable algorithm;determining that the received condition satisfies the preselected condition; andexecuting the predetermined response associated with the selected customizable algorithm.
  • 2. The method of claim 1, further comprising receiving a selection of a clinical care area; and providing one or more customizable algorithms correlated with the selection of the clinical care area for the selection of the customizable algorithm.
  • 3. The method of claim 2, further comprising accessing a database of stored customizable algorithms.
  • 4. The method of claim 1, wherein the selected customizable algorithm comprises a second preselected parameter and a second preselected condition of the second preselected parameter.
  • 5. The method of claim 1, wherein the selected customizable algorithm comprises a Boolean operator to connect two or more preselected parameters, preselected conditions, or predetermined responses.
  • 6. The method of claim 1, wherein the predetermined response comprises one or more of stopping the infusion pump, modifying the rate of infusion, implementing another algorithm, implementing an automatic adjustment of the infusion pump, changing medication, or generating an alarm or remote notification.
  • 7. The method of claim 1, wherein the preselected parameter comprises a change in communication state with an infusion pump.
  • 8. The method of claim 1, wherein the preselected condition comprises one or more of a condition operator, a binary state related to the preselected parameter, a threshold related to the preselected parameter, or a time threshold.
  • 9. A method for implementing a medical system algorithm by an authorized medical caregiver, the method comprising: receiving a condition of a parameter associated with one or more sensors configured to measure the parameter of the patient;receiving a selection of a clinical care area;accessing a database of customizable algorithms, each customizable algorithm comprising a predetermined response, the predetermined response being associated with a preselected parameter and a preselected condition of the preselected parameter, non-terminal parameter symbols and terminal parameter symbols that are configured to be satisfied by a plurality of non-terminal medical device parameters and terminal medical device parameters, non-terminal condition symbols and terminal condition symbols that are configured to be satisfied by a plurality of nonterminal medical device conditions and terminal medical device conditions, and a response symbol that is configured to be satisfied by a plurality of medical system responses; andproviding one or more customizable algorithms correlated with the selection of the clinical care area.
  • 10. The method of claim 9, wherein the one or more customizable algorithms correlated with the selection of clinical care area comprises one customizable algorithm.
  • 11. The method of claim 10, further comprising implementing the one customizable algorithm.
  • 12. The method of claim 9, wherein the one or more customizable algorithms correlated with the selection of clinical care area comprises a plurality of customizable algorithms.
  • 13. The method of claim 12, further comprising: receiving a selection of a customizable algorithm from the plurality of customizable algorithms; andcomparing the received condition of the parameter with the preselected condition of the preselected parameter associated with the selected customizable algorithm.
  • 14. The method of claim 13, further comprising: determining that the received condition satisfies the preselected condition; andexecuting the predetermined response associated with the selected customizable algorithm.
  • 15. The method of claim 13, further comprising: determining that the received condition does not satisfy the preselected condition; andgenerating an alarm.
  • 16. A method for implementing a medical system algorithm by an authorized medical caregiver, the method comprising: receiving a condition of a parameter associated with one or more sensors configured to measure the parameter of the patient;receiving a selection of a customizable algorithm from a plurality of customizable algorithms, each customizable algorithm comprising a predetermined response, the predetermined response being associated with a preselected parameter and a preselected condition of the preselected parameter, wherein the plurality of customizable algorithms comprise non-terminal parameter symbols and terminal parameter symbols that are configured to be satisfied by a plurality of non-terminal medical device parameters and terminal medical device parameters, non-terminal condition symbols and terminal condition symbols that are configured to be satisfied by a plurality of nonterminal medical device conditions and terminal medical device conditions, and a response symbol that is configured to be satisfied by a plurality of medical system responses;comparing the received condition of the parameter with the preselected condition of the preselected parameter associated with the selected customizable algorithm;determining that the received condition does not satisfy the preselected condition; andgenerating an alarm.
  • 17. The method of claim 16, further comprising sending the alarm to a patient monitor interface.
  • 18. The method of claim 16, further comprising: receiving a selection of a clinical care area; andproviding one or more customizable algorithms correlated with the selection of the clinical care area.
  • 19. The method of claim 18, further comprising accessing a database of stored customizable algorithms.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 16/266,622, filed Feb. 4, 2019, which is a continuation of U.S. application Ser. No. 15/467,903, filed Mar. 23, 2017, now U.S. Pat. No. 10,238,801, which is a continuation of U.S. application Ser. No. 13/586,615, filed Aug. 15, 2012, now U.S. Pat. No. 9,604,000, which is a divisional of U.S. application Ser. No. 12/761,107, filed Apr. 15, 2010, now U.S. Pat. No. 8,271,106, which claims priority under 35 U.S.C. 119 from U.S. Provisional No. 61/170,205, filed Apr. 17, 2009, all of which are incorporated by reference herein in their entireties.

US Referenced Citations (1176)
Number Name Date Kind
4024864 Davies et al. May 1977 A
4055175 Clemens et al. Oct 1977 A
4151845 Clemens May 1979 A
4213454 Shim Jul 1980 A
4240438 Updike et al. Dec 1980 A
4280494 Cosgrove et al. Jul 1981 A
4308866 Jeliffe Jan 1982 A
4370983 Lichtenstein et al. Feb 1983 A
4373527 Fischell Feb 1983 A
4392849 Petre et al. Jul 1983 A
4395259 Prestele et al. Jul 1983 A
4457751 Rodler Jul 1984 A
4464170 Clemens Aug 1984 A
4469481 Kobayashi Sep 1984 A
4475901 Kraegen et al. Oct 1984 A
4494950 Fischell Jan 1985 A
4498843 Schneider et al. Feb 1985 A
4515584 Abe et al. May 1985 A
4526568 Clemens et al. Jul 1985 A
4529401 Leslie et al. Jul 1985 A
4543955 Schroeppel Oct 1985 A
4551133 Zegers de Beyl et al. Nov 1985 A
4553958 LeCocq Nov 1985 A
4559037 Franetzki et al. Dec 1985 A
4613937 Batty Sep 1986 A
4624661 Arimond Nov 1986 A
4633878 Bombardieri Jan 1987 A
4634426 Kamen Jan 1987 A
4634427 Hannula et al. Jan 1987 A
4674652 Aten et al. Jun 1987 A
4676776 Howson et al. Jun 1987 A
4679562 Luksha Jul 1987 A
4685903 Cable et al. Aug 1987 A
4695954 Rose Sep 1987 A
4696671 Epstein et al. Sep 1987 A
4714462 DiDomenico Dec 1987 A
4722734 Kolin Feb 1988 A
4731051 Fischell Mar 1988 A
4741732 Crankshaw et al. May 1988 A
4756706 Kerns et al. Jul 1988 A
4776842 Franetzki et al. Oct 1988 A
4785969 McLaughlin Nov 1988 A
4803625 Fu et al. Feb 1989 A
4835372 Gombrich et al. May 1989 A
4838275 Lee Jun 1989 A
4838856 Mulreany et al. Jun 1989 A
4838857 Strowe et al. Jun 1989 A
4854324 Hirschman et al. Aug 1989 A
4857716 Gombrich et al. Aug 1989 A
4858154 Anderson et al. Aug 1989 A
4898578 Rubalcaba, Jr. Feb 1990 A
4908017 Howson et al. Mar 1990 A
4933873 Kaufman et al. Jun 1990 A
4943279 Samiotes et al. Jul 1990 A
4946439 Eggers Aug 1990 A
4953745 Rowlett Sep 1990 A
4978335 Arthur, III Dec 1990 A
5000739 Kulisz et al. Mar 1991 A
5010473 Jacobs Apr 1991 A
5014698 Cohen May 1991 A
5016172 Dessertine May 1991 A
5026084 Paisfield Jun 1991 A
5034004 Crankshaw Jul 1991 A
5041086 Koenig et al. Aug 1991 A
5058161 Weiss Oct 1991 A
5078683 Sancoff et al. Jan 1992 A
5084828 Kaufman et al. Jan 1992 A
5088981 Howson et al. Feb 1992 A
5097505 Weiss Mar 1992 A
5100380 Epstein et al. Mar 1992 A
5102392 Sakai et al. Apr 1992 A
5104374 Bishko et al. Apr 1992 A
5109850 Blanco et al. May 1992 A
5131816 Brown Jul 1992 A
5142484 Kaufman et al. Aug 1992 A
5153827 Coutre et al. Oct 1992 A
5157640 Backner Oct 1992 A
5161222 Montejo et al. Nov 1992 A
5177993 Beckman et al. Jan 1993 A
5181910 Scanlon Jan 1993 A
5190522 Wocicki et al. Mar 1993 A
5199439 Zimmerman et al. Apr 1993 A
5200891 Kehr et al. Apr 1993 A
5216597 Beckers Jun 1993 A
5221268 Barton et al. Jun 1993 A
5230061 Welch Jul 1993 A
5243982 Möstl et al. Sep 1993 A
5244463 Cordner, Jr. et al. Sep 1993 A
5249260 Nigawara et al. Sep 1993 A
5256156 Kern et al. Oct 1993 A
5256157 Samiotes et al. Oct 1993 A
5261702 Mayfield Nov 1993 A
5317506 Coutre et al. May 1994 A
5319355 Russek Jun 1994 A
5319363 Welch et al. Jun 1994 A
5330634 Wong et al. Jul 1994 A
5338157 Blomquist Aug 1994 A
5341476 Lowell Aug 1994 A
5364346 Schrezenmeir Nov 1994 A
5366346 Danby Nov 1994 A
5368562 Blomquist et al. Nov 1994 A
5373454 Kanda et al. Dec 1994 A
5376070 Purvis et al. Dec 1994 A
5378231 Johnson et al. Jan 1995 A
5389071 Kawahara et al. Feb 1995 A
5389078 Zalesky et al. Feb 1995 A
5417222 Dempsey et al. May 1995 A
5423748 Uhala Jun 1995 A
5429602 Hauser Jul 1995 A
5431627 Pastrone et al. Jul 1995 A
5432777 Le Boudec et al. Jul 1995 A
5445621 Poli et al. Aug 1995 A
5447164 Shaya et al. Sep 1995 A
5455851 Chaco et al. Oct 1995 A
5461365 Schlager et al. Oct 1995 A
5464392 Epstein et al. Nov 1995 A
5465082 Chaco Nov 1995 A
5485408 Blomquist Jan 1996 A
5486286 Peterson et al. Jan 1996 A
5493430 Lu et al. Feb 1996 A
5496273 Pastrone et al. Mar 1996 A
5505828 Wong et al. Apr 1996 A
5507288 Bocker et al. Apr 1996 A
5507786 Morgan et al. Apr 1996 A
5508499 Ferrario Apr 1996 A
5515713 Saugues et al. May 1996 A
5520637 Pager et al. May 1996 A
5522798 Johnson et al. Jun 1996 A
5547470 Johnson et al. Aug 1996 A
5554013 Owens et al. Sep 1996 A
5562615 Nassif Oct 1996 A
5577169 Prezioso Nov 1996 A
5582323 Kurtenbach Dec 1996 A
5582593 Hultman Dec 1996 A
5594786 Chaco et al. Jan 1997 A
5598519 Narayanan Jan 1997 A
5620608 Rosa et al. Apr 1997 A
5630710 Tune et al. May 1997 A
5636044 Yuan et al. Jun 1997 A
5643212 Coutre et al. Jul 1997 A
5651775 Walker et al. Jul 1997 A
5658131 Aoki et al. Aug 1997 A
5658250 Blomquist et al. Aug 1997 A
5665065 Colman et al. Sep 1997 A
5669877 Blomquist Sep 1997 A
5672154 Sillén et al. Sep 1997 A
5681285 Ford et al. Oct 1997 A
5685844 Marttila Nov 1997 A
5687717 Halpern et al. Nov 1997 A
5689229 Chaco et al. Nov 1997 A
5697899 Hillman et al. Dec 1997 A
5699509 Gary et al. Dec 1997 A
5713856 Eggers et al. Feb 1998 A
5718562 Lawless et al. Feb 1998 A
5719761 Gatti et al. Feb 1998 A
5733259 Valcke et al. Mar 1998 A
5738102 Lemelson Apr 1998 A
5744027 Connell et al. Apr 1998 A
5752621 Passamante May 1998 A
5754111 Garcia May 1998 A
5764034 Bowman et al. Jun 1998 A
5764159 Neftel et al. Jun 1998 A
5772635 Dastur et al. Jun 1998 A
5774865 Glynn Jun 1998 A
5778256 Darbee Jul 1998 A
5778345 McCartney Jul 1998 A
5781442 Engleson et al. Jul 1998 A
5782805 Meinzer et al. Jul 1998 A
5788669 Peterson Aug 1998 A
5797515 Lift et al. Aug 1998 A
5800387 Duffy et al. Sep 1998 A
5814015 Gargano et al. Sep 1998 A
5822544 Chaco et al. Oct 1998 A
5822715 Worthington et al. Oct 1998 A
5827179 Lichter et al. Oct 1998 A
5832448 Brown Nov 1998 A
5836910 Duffy et al. Nov 1998 A
5850344 Conkright Dec 1998 A
5867821 Ballantyne et al. Feb 1999 A
5870733 Bass et al. Feb 1999 A
5871465 Vasko Feb 1999 A
5873731 Predergast Feb 1999 A
5885245 Lynch et al. Mar 1999 A
5897493 Brown Apr 1999 A
5897498 Canfield, II et al. Apr 1999 A
5910252 Truitt et al. Jun 1999 A
5912818 McGrady et al. Jun 1999 A
5915240 Karpf Jun 1999 A
5920054 Uber, III Jul 1999 A
5920263 Huttenhoff et al. Jul 1999 A
5924074 Evans Jul 1999 A
5931764 Freeman et al. Aug 1999 A
5935099 Peterson et al. Aug 1999 A
5935106 Olsen Aug 1999 A
5941846 Duffy et al. Aug 1999 A
5956501 Brown Sep 1999 A
5957885 Bollish et al. Sep 1999 A
5960085 de la Huerga Sep 1999 A
5961448 Swenson et al. Oct 1999 A
5967559 Abramowitz Oct 1999 A
5971594 Sahai et al. Oct 1999 A
5975081 Hood et al. Nov 1999 A
5990838 Burns et al. Nov 1999 A
5997476 Brown Dec 1999 A
6000828 Leet Dec 1999 A
6003006 Colella et al. Dec 1999 A
6012034 Hamparian et al. Jan 2000 A
6017318 Gauthier et al. Jan 2000 A
6021392 Lester et al. Feb 2000 A
6024539 Blomquist Feb 2000 A
6032155 de la Huerga Feb 2000 A
6032676 Moore Mar 2000 A
6039251 Holowko et al. Mar 2000 A
6073106 Rozen et al. Jun 2000 A
6104295 Gaisser et al. Aug 2000 A
6112182 Akers et al. Aug 2000 A
6112323 Meizlik et al. Aug 2000 A
RE36871 Epstein et al. Sep 2000 E
6115390 Chuah Sep 2000 A
6122536 Sun et al. Sep 2000 A
6126637 Kriesel et al. Oct 2000 A
6135949 Russo et al. Oct 2000 A
6150942 O'Brien Nov 2000 A
6151643 Cheng et al. Nov 2000 A
6157914 Seto et al. Dec 2000 A
6159147 Lichter et al. Dec 2000 A
6167567 Chiles et al. Dec 2000 A
6182667 Hanks et al. Feb 2001 B1
6189105 Lopes Feb 2001 B1
6195589 Ketcham Feb 2001 B1
6208974 Campbell et al. Mar 2001 B1
6222323 Yamashita et al. Apr 2001 B1
6223440 Rashman May 2001 B1
6226277 Chuah May 2001 B1
6227371 Song May 2001 B1
6234176 Domae et al. May 2001 B1
6241704 Peterson et al. Jun 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6249705 Snell Jun 2001 B1
6257265 Brunner et al. Jul 2001 B1
6259355 Chaco et al. Jul 2001 B1
6269340 Ford et al. Jul 2001 B1
6270455 Brown Aug 2001 B1
6271813 Palalau Aug 2001 B1
6277072 Bardy Aug 2001 B1
6280380 Bardy Aug 2001 B1
6283761 Joao Sep 2001 B1
6285665 Chuah Sep 2001 B1
6292860 Cochcroft, Jr. Sep 2001 B1
6312378 Bardy Nov 2001 B1
6327254 Chuah Dec 2001 B1
6330008 Razdow et al. Dec 2001 B1
6339718 Zatezalo et al. Jan 2002 B1
6346886 de la Huerga Feb 2002 B1
6363282 Nichols et al. Mar 2002 B1
6371719 Hildebrandt Apr 2002 B1
6377548 Chuah Apr 2002 B1
6388951 Matsumoto et al. May 2002 B1
6406426 Reuss et al. Jun 2002 B1
6408330 de la Huerga Jun 2002 B1
6418334 Unger et al. Jul 2002 B1
6427088 Bowman et al. Jul 2002 B1
6428483 Carlebach Aug 2002 B1
6442432 Lee Aug 2002 B2
6469991 Chuah Oct 2002 B1
6475180 Peterson et al. Nov 2002 B2
6482158 Mault Nov 2002 B2
6485418 Yasushi et al. Nov 2002 B2
6494694 Lawless et al. Dec 2002 B2
6494831 Koritzinsky Dec 2002 B1
6497680 Holst et al. Dec 2002 B1
6514460 Fendrock Feb 2003 B1
6517482 Eiden et al. Feb 2003 B1
6519569 White et al. Feb 2003 B1
6520930 Critchlow et al. Feb 2003 B2
6540672 Simonsen et al. Apr 2003 B1
6542902 Dulong et al. Apr 2003 B2
6544212 Galley et al. Apr 2003 B2
6544228 Heitmeier Apr 2003 B1
6546350 Hartmann et al. Apr 2003 B1
6551276 Mann et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558320 Causey et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6565509 Say et al. May 2003 B1
6567416 Chuah May 2003 B1
6571294 Simmon et al. May 2003 B2
6572542 Houben et al. Jun 2003 B1
6572545 Knobbe et al. Jun 2003 B2
6578002 Derzay et al. Jun 2003 B1
6581117 Klein et al. Jun 2003 B1
6587034 Heiman et al. Jul 2003 B1
6589229 Connelly et al. Jul 2003 B1
6599281 Struys et al. Jul 2003 B1
6602191 Quy Aug 2003 B2
6605072 Struys et al. Aug 2003 B2
6628809 Rowe et al. Sep 2003 B1
6631353 Davis et al. Oct 2003 B1
6640246 Gardy, Jr. et al. Oct 2003 B1
6641533 Causey, III et al. Nov 2003 B2
6647299 Bourget Nov 2003 B2
6652455 Kocher Nov 2003 B1
6653937 Nelson et al. Nov 2003 B2
6659947 Carter et al. Dec 2003 B1
6669630 Joliat et al. Dec 2003 B1
6671563 Engleson et al. Dec 2003 B1
6673033 Sciulli et al. Jan 2004 B1
6674403 Gray et al. Jan 2004 B2
6681003 Linder et al. Jan 2004 B2
6689091 Bui et al. Feb 2004 B2
6692241 Watanabe et al. Feb 2004 B2
6694191 Starkweather et al. Feb 2004 B2
6694334 DuLong et al. Feb 2004 B2
6721286 Williams et al. Apr 2004 B1
6721582 Trepagnier et al. Apr 2004 B2
6725200 Rost Apr 2004 B1
6731989 Engleson et al. May 2004 B2
6740072 Starkweather et al. May 2004 B2
6751651 Crockett Jun 2004 B2
6752787 Causey, III et al. Jun 2004 B1
6753830 Gelbman Jun 2004 B2
6758810 Lebel et al. Jul 2004 B2
6773396 Flach et al. Aug 2004 B2
6774786 Havekost et al. Aug 2004 B1
6775577 Cmkovich et al. Aug 2004 B2
6780156 Haueter et al. Aug 2004 B2
6790198 White et al. Sep 2004 B1
6796956 Hartlaub et al. Sep 2004 B2
6799149 Hartlaub Sep 2004 B2
6809653 Mann et al. Oct 2004 B1
6811534 Bowman, IV et al. Nov 2004 B2
6816605 Rowe et al. Nov 2004 B2
6839753 Biondi et al. Jan 2005 B2
6852104 Blomquist Feb 2005 B2
6859134 Heiman et al. Feb 2005 B1
6871211 Labounty et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6876303 Reeder et al. Apr 2005 B2
6885881 Leonhardt Apr 2005 B2
6891525 Ogoro May 2005 B2
6892278 Ebergen May 2005 B2
6899695 Herrera May 2005 B2
6915170 Engleson et al. Jul 2005 B2
6923763 Kovatchev et al. Aug 2005 B1
6924781 Gelbman Aug 2005 B1
6928338 Buchser et al. Aug 2005 B1
6936029 Mann et al. Aug 2005 B2
6945954 Hochman et al. Sep 2005 B2
6948492 Wemeling et al. Sep 2005 B2
6958677 Carter Oct 2005 B1
6958691 Anderson et al. Oct 2005 B1
6958705 Lebel et al. Oct 2005 B2
6961448 Nichols et al. Nov 2005 B2
6969352 Chiang et al. Nov 2005 B2
6969865 Duchon et al. Nov 2005 B2
6974437 Lebel et al. Dec 2005 B2
6979326 Mann et al. Dec 2005 B2
6980958 Surwit et al. Dec 2005 B1
6985870 Martucci et al. Jan 2006 B2
6986347 Hickle Jan 2006 B2
6997880 Carlebach et al. Feb 2006 B2
6997920 Mann et al. Feb 2006 B2
6998984 Zittrain Feb 2006 B1
7017293 Riley Mar 2006 B2
7025743 Mann et al. Apr 2006 B2
7029455 Flaherty Apr 2006 B2
7038584 Carter May 2006 B2
7060031 Webb et al. Jun 2006 B2
7060059 Keith et al. Jun 2006 B2
7069552 Lindberg et al. Jun 2006 B2
7072725 Bristol et al. Jul 2006 B2
7079035 Bock et al. Jul 2006 B2
7092943 Roese et al. Aug 2006 B2
7096072 Engleson et al. Aug 2006 B2
7099809 Dori Aug 2006 B2
7103419 Engleson et al. Sep 2006 B2
7103578 Beck et al. Sep 2006 B2
7107106 Engleson et al. Sep 2006 B2
7108680 Rohr et al. Sep 2006 B2
7109878 Mann et al. Sep 2006 B2
7114002 Okumura et al. Sep 2006 B1
7117041 Engleson et al. Oct 2006 B2
7136645 Hanson et al. Nov 2006 B2
7137964 Flaherty Nov 2006 B2
7142190 Martinez Nov 2006 B2
7150741 Erickson et al. Dec 2006 B2
7153289 Vasko Dec 2006 B2
7154397 Zerhusen et al. Dec 2006 B2
7156807 Carter et al. Jan 2007 B2
7158030 Chung Jan 2007 B2
7161484 Tsoukalis et al. Jan 2007 B2
7167755 Seeberger et al. Jan 2007 B2
7167920 Traversal Jan 2007 B2
7171277 Engleson et al. Jan 2007 B2
7171492 Borella et al. Jan 2007 B1
7181493 English et al. Feb 2007 B2
7185288 McKeever Feb 2007 B2
7193514 Ritson Mar 2007 B2
7197025 Chuah Mar 2007 B2
7201734 Hickle Apr 2007 B2
7204823 Estes et al. Apr 2007 B2
7213009 Pestotnik May 2007 B2
7216802 de la Huerga May 2007 B1
7220240 Struys et al. May 2007 B2
7224979 Singhal et al. May 2007 B2
7229430 Hickle et al. Jun 2007 B2
7230529 Ketcherside Jun 2007 B2
7236936 White et al. Jun 2007 B2
7238164 Childers et al. Jul 2007 B2
7247154 Hickle Jul 2007 B2
7248239 Dowling Jul 2007 B2
7250856 Havekost et al. Jul 2007 B2
7255683 Vanderveen et al. Aug 2007 B2
7256888 Staehr et al. Aug 2007 B2
7258534 Fathallah et al. Aug 2007 B2
7263213 Rowe Aug 2007 B2
7267664 Rizzo Sep 2007 B2
7267665 Steil et al. Sep 2007 B2
7275156 Balfanz et al. Sep 2007 B2
7278983 Ireland et al. Oct 2007 B2
7289815 Gfeller et al. Oct 2007 B2
7289948 Mohri Oct 2007 B1
7293107 Hanson et al. Nov 2007 B1
7295119 Rappaport et al. Nov 2007 B2
7295556 Roese et al. Nov 2007 B2
7301451 Hastings Nov 2007 B2
7308300 Toews et al. Dec 2007 B2
7315825 Rosenfeld et al. Jan 2008 B2
7319386 Collins, Jr. et al. Jan 2008 B2
7324000 Zittrain et al. Jan 2008 B2
7327705 Fletcher et al. Feb 2008 B2
7343224 DiGianfilippo et al. Mar 2008 B2
7346025 Bryson Mar 2008 B2
7347836 Peterson et al. Mar 2008 B2
7354420 Steil et al. Apr 2008 B2
7369897 Boveja et al. May 2008 B2
7369948 Ferenczi et al. May 2008 B1
7383088 Spinelli et al. Jun 2008 B2
7384410 Eggers et al. Jun 2008 B2
7398183 Holland et al. Jul 2008 B2
7398279 Muno, Jr. et al. Jul 2008 B2
7399277 Saidara et al. Jul 2008 B2
7402153 Steil et al. Jul 2008 B2
7420472 Tran Sep 2008 B2
7432807 Schmitt Oct 2008 B2
7447643 Olson Nov 2008 B1
7454314 Holland et al. Nov 2008 B2
7457804 Uber, III et al. Nov 2008 B2
7464040 Joao Dec 2008 B2
7471994 Ford et al. Dec 2008 B2
7483756 Engleson et al. Jan 2009 B2
7489808 Gerder Feb 2009 B2
7490021 Holland et al. Feb 2009 B2
7490048 Joao Feb 2009 B2
7491187 Van Den Berghe et al. Feb 2009 B2
7519905 Kougiouris et al. Apr 2009 B2
7523401 Aldridge Apr 2009 B1
7524304 Genosar Apr 2009 B2
7551078 Carlson Jun 2009 B2
7559321 Wermeling et al. Jul 2009 B2
7565197 Haulbrich et al. Jul 2009 B2
7572230 Neumann et al. Aug 2009 B2
7578802 Hickle Aug 2009 B2
7621009 Elhabashy Nov 2009 B2
D606533 De Jong et al. Dec 2009 S
7636718 Steen et al. Dec 2009 B1
7640172 Kuth Dec 2009 B2
7645258 White et al. Jan 2010 B2
7647237 Malave et al. Jan 2010 B2
7662124 Duchon et al. Feb 2010 B2
7668731 Martucci et al. Feb 2010 B2
7671733 McNeal et al. Mar 2010 B2
7678071 Lebel et al. Mar 2010 B2
7687678 Jacobs Mar 2010 B2
7697994 VanDanacker et al. Apr 2010 B2
7698239 Lieuallen Apr 2010 B2
7705727 Pestotnik Apr 2010 B2
7724147 Brown et al. May 2010 B2
7739126 Cave Jun 2010 B1
7746218 Collins, Jr. Jun 2010 B2
7766873 Moberg et al. Aug 2010 B2
7776029 Whitehurst et al. Aug 2010 B2
7776031 Hartlaub et al. Aug 2010 B2
7785313 Mastrototaro Aug 2010 B2
7806852 Jurson Oct 2010 B1
7806886 Kanderian, Jr. et al. Oct 2010 B2
7826981 Goode, Jr. et al. Nov 2010 B2
7835927 Schlotterbeck et al. Nov 2010 B2
7836314 Chieu Nov 2010 B2
7856276 Ripart et al. Dec 2010 B2
7860583 Condurso et al. Dec 2010 B2
7868754 Salvat, Jr. Jan 2011 B2
7871394 Halbert et al. Jan 2011 B2
7886231 Hopermann et al. Feb 2011 B2
7895053 Holland et al. Feb 2011 B2
7896842 Palmroos et al. Mar 2011 B2
7899546 Sieracki et al. Mar 2011 B2
7905710 Wang et al. Mar 2011 B2
7920061 Klein et al. Apr 2011 B2
7933780 de la Huerga Apr 2011 B2
7938796 Moubayed May 2011 B2
7945452 Fathallah et al. May 2011 B2
7974714 Hoffberg Jul 2011 B2
7976508 Hoag Jul 2011 B2
7996241 Zak Aug 2011 B2
8034026 Grant Oct 2011 B2
8038593 Friedman et al. Oct 2011 B2
8048040 Kiani Nov 2011 B2
8060576 Chan et al. Nov 2011 B2
8065161 Howard et al. Nov 2011 B2
8066672 Mandro Nov 2011 B2
8075514 Butterfield et al. Dec 2011 B2
8078983 Davis et al. Dec 2011 B2
8082018 Duchon et al. Dec 2011 B2
8082312 Chan et al. Dec 2011 B2
8095692 Mehta et al. Jan 2012 B2
8147448 Sundar et al. Apr 2012 B2
8149131 Blomquist Apr 2012 B2
8169914 Bajpai May 2012 B2
8171094 Chan et al. May 2012 B2
8172798 Hungerford et al. May 2012 B2
8185322 Schroeder et al. May 2012 B2
8195478 Petersen et al. Jun 2012 B2
8206350 Mann et al. Jun 2012 B2
8219413 Martinez et al. Jul 2012 B2
8231578 Fathallah et al. Jul 2012 B2
8234128 Martucci et al. Jul 2012 B2
8267892 Spencer et al. Sep 2012 B2
8271106 Wehba et al. Sep 2012 B2
8287495 Michaud et al. Oct 2012 B2
8291337 Gannin et al. Oct 2012 B2
8298184 DiPerna et al. Oct 2012 B2
8312272 Serenyl et al. Nov 2012 B1
8352290 Bartz et al. Jan 2013 B2
8359338 Butterfield et al. Jan 2013 B2
8380536 Howard et al. Feb 2013 B2
8387112 Ranjan et al. Feb 2013 B1
8394077 Jacobson et al. Mar 2013 B2
8398592 Leibner-Druska Mar 2013 B2
8403908 Jacobson et al. Mar 2013 B2
8435206 Evans et al. May 2013 B2
8449523 Brukalo et al. May 2013 B2
8452953 Buck et al. May 2013 B2
8453645 Figueiredo et al. Jun 2013 B2
8480648 Burnett et al. Jul 2013 B2
8489427 Simpson et al. Jul 2013 B2
8494879 Davis et al. Jul 2013 B2
8504179 Blomquist Aug 2013 B2
8517990 Teel et al. Aug 2013 B2
8518021 Stewart et al. Aug 2013 B2
8543416 Palmroos et al. Sep 2013 B2
8551038 Tsoukalis et al. Oct 2013 B2
8560345 Wehba et al. Oct 2013 B2
8577692 Silkaitis et al. Nov 2013 B2
8579884 Lanier et al. Nov 2013 B2
8626530 Tran et al. Jan 2014 B1
8655676 Wehba et al. Feb 2014 B2
8660860 Wehba et al. Feb 2014 B2
8662388 Belkin Mar 2014 B2
8666769 Butler et al. Mar 2014 B2
8700421 Feng et al. Apr 2014 B2
8731960 Butler et al. May 2014 B2
8768719 Wehba et al. Jul 2014 B2
8771251 Ruchti et al. Jul 2014 B2
8777894 Butterfield et al. Jul 2014 B2
8777895 Hsu et al. Jul 2014 B2
8799012 Butler et al. Aug 2014 B2
8876793 Ledford et al. Nov 2014 B2
8922330 Moberg et al. Dec 2014 B2
8936565 Chawla Jan 2015 B2
8952794 Blomquist et al. Feb 2015 B2
8998100 Halbert et al. Apr 2015 B2
9026370 Rubalcaba et al. May 2015 B2
9069887 Gupta et al. Jun 2015 B2
9077544 Baker et al. Jul 2015 B2
9089642 Murphy et al. Jul 2015 B2
9114217 Sur et al. Aug 2015 B2
9123077 Silkaitis et al. Sep 2015 B2
9192712 DeBelser et al. Nov 2015 B2
9240002 Hume et al. Jan 2016 B2
9381296 Arrizza et al. Jul 2016 B2
9393362 Cozmi et al. Jul 2016 B2
9483615 Roberts Nov 2016 B2
9498583 Sur et al. Nov 2016 B2
9539383 Kohlbrecher Jan 2017 B2
9572923 Howard et al. Feb 2017 B2
9594875 Arrizza et al. Mar 2017 B2
9604000 Wehba et al. Mar 2017 B2
9641432 Jha et al. May 2017 B2
9649431 Gray et al. May 2017 B2
9662436 Belkin et al. May 2017 B2
9690909 Stewart et al. Jun 2017 B2
9707341 Dumas, III et al. Jul 2017 B2
9724470 Day et al. Aug 2017 B2
9764082 Day et al. Sep 2017 B2
9886550 Lee et al. Feb 2018 B2
9943269 Muhsin et al. Apr 2018 B2
9971871 Arrizza et al. May 2018 B2
9995611 Ruchti et al. Jun 2018 B2
10022498 Ruchti et al. Jul 2018 B2
10042986 Ruchti et al. Aug 2018 B2
10046112 Oruklu et al. Aug 2018 B2
10166328 Oruklu et al. Jan 2019 B2
10173008 Simpson et al. Jan 2019 B2
10238799 Kohlbrecher Mar 2019 B2
10238801 Wehba et al. Mar 2019 B2
10242060 Butler et al. Mar 2019 B2
10300194 Day et al. May 2019 B2
10311972 Kohlbrecher et al. Jun 2019 B2
10314974 Day et al. Jun 2019 B2
10333843 Jha et al. Jun 2019 B2
10430761 Hume et al. Oct 2019 B2
10434246 Silkaitis et al. Oct 2019 B2
10463788 Day Nov 2019 B2
10617815 Day et al. Apr 2020 B2
10646651 Day et al. May 2020 B2
10692595 Xavier et al. Jun 2020 B2
10741280 Xavier et al. Aug 2020 B2
10757219 Moskal Aug 2020 B2
10765799 Belkin et al. Sep 2020 B2
10799632 Kohlbrecher Oct 2020 B2
10812380 Jha et al. Oct 2020 B2
10861592 Xavier et al. Dec 2020 B2
10898641 Day et al. Jan 2021 B2
10950339 Xavier et al. Mar 2021 B2
10964428 Xavier et al. Mar 2021 B2
11013861 Wehba et al. May 2021 B2
11037668 Ruchti et al. Jun 2021 B2
20010016056 Westphal et al. Aug 2001 A1
20010031944 Peterson et al. Oct 2001 A1
20010032099 Joao Oct 2001 A1
20010037060 Thompson et al. Nov 2001 A1
20010044731 Coffman et al. Nov 2001 A1
20010048027 Walsh Dec 2001 A1
20010051787 Haller et al. Dec 2001 A1
20010056358 Dulong et al. Dec 2001 A1
20020010595 Kapp Jan 2002 A1
20020013551 Zaitsu et al. Jan 2002 A1
20020013723 Mise Jan 2002 A1
20020015018 Shimazu et al. Feb 2002 A1
20020019584 Schulze et al. Feb 2002 A1
20020021700 Hata et al. Feb 2002 A1
20020026103 Norris et al. Feb 2002 A1
20020029776 Blomquist Mar 2002 A1
20020032583 Joao Mar 2002 A1
20020038206 Dori Mar 2002 A1
20020040208 Flaherty et al. Apr 2002 A1
20020040282 Bailey et al. Apr 2002 A1
20020082728 Mueller et al. Jun 2002 A1
20020087115 Hartlaub Jul 2002 A1
20020087116 Hartlaub Jul 2002 A1
20020095486 Bahl Jul 2002 A1
20020103675 Vanelli Aug 2002 A1
20020123905 Goodroe et al. Sep 2002 A1
20020143580 Bristol et al. Oct 2002 A1
20020152239 Bautista-Lloyd et al. Oct 2002 A1
20020154600 Ido et al. Oct 2002 A1
20020173702 Lebel et al. Nov 2002 A1
20020173875 Wallace et al. Nov 2002 A1
20020194329 Alling Dec 2002 A1
20030009244 Engleson Jan 2003 A1
20030013959 Grunwald et al. Jan 2003 A1
20030014222 Klass et al. Jan 2003 A1
20030014817 Gallant et al. Jan 2003 A1
20030025602 Medema et al. Feb 2003 A1
20030028082 Thompson Feb 2003 A1
20030036683 Kehr et al. Feb 2003 A1
20030036744 Struys et al. Feb 2003 A1
20030047126 Tomaschko Mar 2003 A1
20030050621 Lebel et al. Mar 2003 A1
20030059750 Bindler et al. Mar 2003 A1
20030060688 Ciarniello et al. Mar 2003 A1
20030069963 Jayant et al. Apr 2003 A1
20030079746 Hickle May 2003 A1
20030097529 Arimilli et al. May 2003 A1
20030104982 Wittmann et al. Jun 2003 A1
20030106553 Vanderveen Jun 2003 A1
20030115358 Yun Jun 2003 A1
20030120384 Haitin et al. Jun 2003 A1
20030125662 Bui Jul 2003 A1
20030130616 Steil Jul 2003 A1
20030135087 Hickle et al. Jul 2003 A1
20030139701 White et al. Jul 2003 A1
20030140928 Bui et al. Jul 2003 A1
20030140929 Wilkes et al. Jul 2003 A1
20030141981 Bui et al. Jul 2003 A1
20030143746 Sage, Jr. Jul 2003 A1
20030144878 Wilkes et al. Jul 2003 A1
20030158749 Olchanski et al. Aug 2003 A1
20030187338 Say et al. Oct 2003 A1
20030200116 Forrester Oct 2003 A1
20030204416 Acharya Oct 2003 A1
20030204781 Peebles et al. Oct 2003 A1
20030212364 Mann et al. Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20030212821 Gillies et al. Nov 2003 A1
20030217962 Childers et al. Nov 2003 A1
20040008123 Carrender et al. Jan 2004 A1
20040015132 Brown Jan 2004 A1
20040019607 Moubayed et al. Jan 2004 A1
20040030323 Ullestad et al. Feb 2004 A1
20040039257 Hickle Feb 2004 A1
20040057226 Berthou et al. Mar 2004 A1
20040064341 Langan et al. Apr 2004 A1
20040064342 Browne et al. Apr 2004 A1
20040064435 Moubayed et al. Apr 2004 A1
20040073811 Sanin Apr 2004 A1
20040077934 Massad Apr 2004 A1
20040078231 Wilkes et al. Apr 2004 A1
20040078236 Stoodley et al. Apr 2004 A1
20040104271 Martucci et al. Jun 2004 A1
20040122530 Hansen Jun 2004 A1
20040128162 Schlotterbeck et al. Jul 2004 A1
20040128163 Goodman et al. Jul 2004 A1
20040133441 Brady et al. Jul 2004 A1
20040139004 Cohen et al. Jul 2004 A1
20040145480 Despotis Jul 2004 A1
20040147034 Gore et al. Jul 2004 A1
20040167464 Ireland et al. Aug 2004 A1
20040167465 Kohler Aug 2004 A1
20040167804 Simpson Aug 2004 A1
20040172222 Simpson et al. Sep 2004 A1
20040172283 Vanderveen Sep 2004 A1
20040172301 Mihai et al. Sep 2004 A1
20040172302 Martucci et al. Sep 2004 A1
20040176667 Mihai et al. Sep 2004 A1
20040176980 Bulitta et al. Sep 2004 A1
20040176984 White et al. Sep 2004 A1
20040181314 Zaleski Sep 2004 A1
20040189708 Larcheveque et al. Sep 2004 A1
20040193325 Bonderud Sep 2004 A1
20040193328 Butterfield et al. Sep 2004 A1
20040193453 Butterfield et al. Sep 2004 A1
20040204673 Flaherty et al. Oct 2004 A1
20040215278 Stegink et al. Oct 2004 A1
20040220517 Starkweather et al. Nov 2004 A1
20040225252 Gillespie et al. Nov 2004 A1
20040236240 Kraus et al. Nov 2004 A1
20040243438 Mintz Dec 2004 A1
20040254434 Goodnow et al. Dec 2004 A1
20050010269 Lebel et al. Jan 2005 A1
20050020886 Hutchinson et al. Jan 2005 A1
20050021006 Tonnies Jan 2005 A1
20050027560 Cook Feb 2005 A1
20050027567 Taha Feb 2005 A1
20050038311 Kuth Feb 2005 A1
20050038669 Sachdeva et al. Feb 2005 A1
20050038680 McMahon Feb 2005 A1
20050040226 Al-Sheikh Feb 2005 A1
20050043620 Fallows et al. Feb 2005 A1
20050049910 Lancaster et al. Mar 2005 A1
20050055242 Bello et al. Mar 2005 A1
20050055244 Mullan et al. Mar 2005 A1
20050065465 Lebel et al. Mar 2005 A1
20050065817 Mihai et al. Mar 2005 A1
20050075544 Shapiro et al. Apr 2005 A1
20050080801 Kothandaraman et al. Apr 2005 A1
20050086071 Fox, Jr. et al. Apr 2005 A1
20050086072 Fox Apr 2005 A1
20050090808 Malave et al. Apr 2005 A1
20050099624 Staehr May 2005 A1
20050102162 Blumenfeld May 2005 A1
20050102165 Oshita et al. May 2005 A1
20050102167 Kapoor May 2005 A1
20050102669 Marney et al. May 2005 A1
20050107923 Vanderveen May 2005 A1
20050108057 Cohen et al. May 2005 A1
20050117529 Ramos-Escano Jun 2005 A1
20050119788 Engleson et al. Jun 2005 A1
20050119914 Batch Jun 2005 A1
20050131739 Rabinowitz et al. Jun 2005 A1
20050135306 McAllen et al. Jun 2005 A1
20050137522 Aoki Jun 2005 A1
20050137573 McLaughlin Jun 2005 A1
20050154769 Eckart et al. Jul 2005 A1
20050160057 Wefers et al. Jul 2005 A1
20050171503 Van Den Berghe et al. Aug 2005 A1
20050171815 Vanderveen Aug 2005 A1
20050177096 Bollish et al. Aug 2005 A1
20050177395 Blomquist Aug 2005 A1
20050182306 Sloan Aug 2005 A1
20050182355 Bui Aug 2005 A1
20050187950 Parker Aug 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20050197554 Polcha Sep 2005 A1
20050197621 Poulsen et al. Sep 2005 A1
20050210037 Wefers et al. Sep 2005 A1
20050216479 Wefers et al. Sep 2005 A1
20050216480 Wefers et al. Sep 2005 A1
20050223045 Funahashi et al. Oct 2005 A1
20050224083 Crass Oct 2005 A1
20050234746 Funahashi Oct 2005 A1
20050240305 Bogash et al. Oct 2005 A1
20050246416 Blomquist Nov 2005 A1
20050251418 Fox, Jr. et al. Nov 2005 A1
20050261660 Choi Nov 2005 A1
20050273059 Mernoe et al. Dec 2005 A1
20050273367 Nourie et al. Dec 2005 A1
20050277873 Stewart et al. Dec 2005 A1
20050277890 Stewart et al. Dec 2005 A1
20050277911 Stewart et al. Dec 2005 A1
20050278194 Holland et al. Dec 2005 A1
20060004772 Hagan et al. Jan 2006 A1
20060009727 O'Mahony et al. Jan 2006 A1
20060009734 Martin Jan 2006 A1
20060010098 Goodnow et al. Jan 2006 A1
20060042139 Mendes Mar 2006 A1
20060047270 Shelton Mar 2006 A1
20060047538 Condurso Mar 2006 A1
20060053036 Coffman et al. Mar 2006 A1
20060064020 Burnes et al. Mar 2006 A1
20060074633 Mahesh et al. Apr 2006 A1
20060074920 Wefers et al. Apr 2006 A1
20060079831 Gilbert Apr 2006 A1
20060089854 Holland et al. Apr 2006 A1
20060089855 Holland et al. Apr 2006 A1
20060100746 Leibner-Druska May 2006 A1
20060100907 Holland et al. May 2006 A1
20060106649 Eggers et al. May 2006 A1
20060111943 Wu May 2006 A1
20060116904 Brem Jun 2006 A1
20060116907 Rhodes et al. Jun 2006 A1
20060122481 Sievenpiper et al. Jun 2006 A1
20060122867 Eggers et al. Jun 2006 A1
20060129140 Todd et al. Jun 2006 A1
20060129429 Moubayed et al. Jun 2006 A1
20060129434 Smitherman et al. Jun 2006 A1
20060129435 Smitherman et al. Jun 2006 A1
20060136266 Tarassenko et al. Jun 2006 A1
20060136271 Eggers et al. Jun 2006 A1
20060143051 Eggers et al. Jun 2006 A1
20060173260 Gaoni et al. Aug 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060173715 Wang et al. Aug 2006 A1
20060173927 Beyer et al. Aug 2006 A1
20060190302 Eggers et al. Aug 2006 A1
20060195022 Trepagnier et al. Aug 2006 A1
20060200007 Brockway et al. Sep 2006 A1
20060200369 Batch et al. Sep 2006 A1
20060211404 Cromp et al. Sep 2006 A1
20060224141 Rush et al. Oct 2006 A1
20060229918 Fotsch et al. Oct 2006 A1
20060258985 Russell Nov 2006 A1
20060259327 Hoag Nov 2006 A1
20060264895 Flanders Nov 2006 A1
20060265246 Hoag Nov 2006 A1
20060267753 Hussey et al. Nov 2006 A1
20060268710 Appanna et al. Nov 2006 A1
20060277206 Bailey et al. Dec 2006 A1
20060287885 Frick Dec 2006 A1
20070015972 Wang et al. Jan 2007 A1
20070016443 Wachman et al. Jan 2007 A1
20070027506 Stender et al. Feb 2007 A1
20070060796 Kim Mar 2007 A1
20070060870 Tolle et al. Mar 2007 A1
20070060871 Istoc Mar 2007 A1
20070061393 Moore Mar 2007 A1
20070065363 Dalal et al. Mar 2007 A1
20070073419 Sesay Mar 2007 A1
20070078314 Grounsell Apr 2007 A1
20070083870 Kanakogi Apr 2007 A1
20070088333 Levin et al. Apr 2007 A1
20070093786 Goldsmith et al. Apr 2007 A1
20070100665 Brown May 2007 A1
20070100667 Bardy May 2007 A1
20070106126 Mannheimer et al. May 2007 A1
20070112298 Mueller et al. May 2007 A1
20070116037 Moore May 2007 A1
20070118405 Campbell et al. May 2007 A1
20070135866 Baker et al. Jun 2007 A1
20070136098 Smythe et al. Jun 2007 A1
20070142822 Remde Jun 2007 A1
20070156282 Dunn Jul 2007 A1
20070156452 Batch Jul 2007 A1
20070169008 Varanasi et al. Jul 2007 A1
20070179448 Lim et al. Aug 2007 A1
20070186923 Poutiatine et al. Aug 2007 A1
20070191817 Martin Aug 2007 A1
20070191973 Holzbauer et al. Aug 2007 A1
20070213657 Jennewine et al. Sep 2007 A1
20070213684 Hickle et al. Sep 2007 A1
20070214003 Holland et al. Sep 2007 A1
20070215545 Bissler et al. Sep 2007 A1
20070229249 McNeal et al. Oct 2007 A1
20070232867 Hansmann Oct 2007 A1
20070233035 Wehba et al. Oct 2007 A1
20070233049 Wehba et al. Oct 2007 A1
20070233206 Kart Oct 2007 A1
20070233520 Wehba et al. Oct 2007 A1
20070251835 Mehta et al. Nov 2007 A1
20070253021 Mehta et al. Nov 2007 A1
20070254593 Jollota et al. Nov 2007 A1
20070255125 Moberg et al. Nov 2007 A1
20070257788 Carlson Nov 2007 A1
20070258395 Jollota et al. Nov 2007 A1
20070299389 Halbert et al. Dec 2007 A1
20070299687 Palmer et al. Dec 2007 A1
20070299695 Jung et al. Dec 2007 A1
20080004904 Tran Jan 2008 A1
20080009684 Corsetti et al. Jan 2008 A1
20080033361 Evans et al. Feb 2008 A1
20080033966 Wahl Feb 2008 A1
20080034323 Blomquist Feb 2008 A1
20080041942 Aissa Feb 2008 A1
20080052704 Wysocki Feb 2008 A1
20080065007 Peterson et al. Mar 2008 A1
20080065417 Jung et al. Mar 2008 A1
20080071217 Moubayed et al. Mar 2008 A1
20080071251 Moubayed et al. Mar 2008 A1
20080091466 Butler et al. Apr 2008 A1
20080095339 Elliott Apr 2008 A1
20080097289 Steil et al. Apr 2008 A1
20080126969 Blomquist May 2008 A1
20080139907 Rao et al. Jun 2008 A1
20080149117 Raghuram Jun 2008 A1
20080154177 Moubayed et al. Jun 2008 A1
20080172337 Banfield et al. Jul 2008 A1
20080184219 Matsumoto Jul 2008 A1
20080188796 Steil et al. Aug 2008 A1
20080200870 Palmroos et al. Aug 2008 A1
20080214919 Harmon et al. Sep 2008 A1
20080243055 Fathallah et al. Oct 2008 A1
20080246748 Cassidy et al. Oct 2008 A1
20080256305 Kwon Oct 2008 A1
20080259926 Tavares et al. Oct 2008 A1
20080262469 Bristol et al. Oct 2008 A1
20080269714 Mastrototaro et al. Oct 2008 A1
20080269723 Mastrototaro et al. Oct 2008 A1
20080275384 Mastrototaro et al. Nov 2008 A1
20080300572 Rankers et al. Dec 2008 A1
20080320387 Sasaki et al. Dec 2008 A1
20080320466 Dias Dec 2008 A1
20090003554 Katis et al. Jan 2009 A1
20090005703 Fasciano Jan 2009 A1
20090005728 Weinert et al. Jan 2009 A1
20090006061 Thukral et al. Jan 2009 A1
20090006129 Thukral Jan 2009 A1
20090006133 Weinert Jan 2009 A1
20090018495 Panduro Jan 2009 A1
20090051560 Manning et al. Feb 2009 A1
20090054743 Stewart Feb 2009 A1
20090054754 McMahon et al. Feb 2009 A1
20090057399 Sajkowsky Mar 2009 A1
20090063187 Johnson et al. Mar 2009 A1
20090069785 Miller et al. Mar 2009 A1
20090099867 Newman Apr 2009 A1
20090135196 Holland et al. May 2009 A1
20090143662 Estes et al. Jun 2009 A1
20090149743 Barron et al. Jun 2009 A1
20090150174 Buck et al. Jun 2009 A1
20090150439 Gejdos et al. Jun 2009 A1
20090150878 Pathak et al. Jun 2009 A1
20090156991 Roberts Jun 2009 A1
20090157695 Roberts Jun 2009 A1
20090158274 Roberts Jun 2009 A1
20090177146 Nesbitt et al. Jul 2009 A1
20090177769 Roberts Jul 2009 A1
20090177992 Rubalcaba et al. Jul 2009 A1
20090183147 Davis et al. Jul 2009 A1
20090209938 Aalto-Setala Aug 2009 A1
20090210250 Prax et al. Aug 2009 A1
20090221890 Saffer et al. Sep 2009 A1
20090231249 Wang et al. Sep 2009 A1
20090270833 DeBelser Oct 2009 A1
20090275886 Blomquist et al. Nov 2009 A1
20090275896 Kamen et al. Nov 2009 A1
20090284691 Marhefka et al. Nov 2009 A1
20090292340 Mass et al. Nov 2009 A1
20090326340 Wang Dec 2009 A1
20090326516 Bangera et al. Dec 2009 A1
20100022988 Wochner Jan 2010 A1
20100036310 Hillman Feb 2010 A1
20100056992 Hayter Mar 2010 A1
20100083060 Rahman Apr 2010 A1
20100095229 Dixon et al. Apr 2010 A1
20100121170 Rule May 2010 A1
20100121415 Skelton et al. May 2010 A1
20100121654 Portnoy et al. May 2010 A1
20100121752 Banigan et al. May 2010 A1
20100130933 Holland et al. May 2010 A1
20100131434 Magent et al. May 2010 A1
20100138523 Umess et al. Jun 2010 A1
20100146137 Wu et al. Jun 2010 A1
20100156633 Buck et al. Jun 2010 A1
20100160854 Gauthier Jun 2010 A1
20100160860 Celentano et al. Jun 2010 A1
20100174266 Estes Jul 2010 A1
20100191525 Rabenko et al. Jul 2010 A1
20100198034 Thomas et al. Aug 2010 A1
20100198196 Wei Aug 2010 A1
20100200506 Ware et al. Aug 2010 A1
20100209268 Davis Aug 2010 A1
20100212675 Walling et al. Aug 2010 A1
20100217621 Schoenberg Aug 2010 A1
20100234708 Buck et al. Sep 2010 A1
20100250732 Bucknell Sep 2010 A1
20100268157 Wehba et al. Oct 2010 A1
20100271479 Heydlauf Oct 2010 A1
20100273738 Valcke et al. Oct 2010 A1
20100274218 Yodfat et al. Oct 2010 A1
20100280486 Khair et al. Nov 2010 A1
20100292634 Kircher Nov 2010 A1
20100298765 Budiman et al. Nov 2010 A1
20100318025 John Dec 2010 A1
20110001605 Kiani et al. Jan 2011 A1
20110021898 Wei et al. Jan 2011 A1
20110040158 Katz et al. Feb 2011 A1
20110060758 Schlotterbeck et al. Mar 2011 A1
20110071844 Cannon et al. Mar 2011 A1
20110072379 Gannon Mar 2011 A1
20110078608 Gannon et al. Mar 2011 A1
20110093284 Dicks et al. Apr 2011 A1
20110099313 Bolanowski Apr 2011 A1
20110125095 Lebel et al. May 2011 A1
20110138185 Ju et al. Jun 2011 A1
20110175728 Baker, Jr. Jul 2011 A1
20110178462 Moberg et al. Jul 2011 A1
20110196748 Caron et al. Aug 2011 A1
20110231216 Fyke et al. Sep 2011 A1
20110257496 Terashima et al. Oct 2011 A1
20110257798 Ali et al. Oct 2011 A1
20110259954 Bartz et al. Oct 2011 A1
20110264043 Kotnick et al. Oct 2011 A1
20110264044 Bartz et al. Oct 2011 A1
20110266221 Ware et al. Nov 2011 A1
20110270045 Lebel et al. Nov 2011 A1
20110275904 Lebel et al. Nov 2011 A1
20110286457 Ee Nov 2011 A1
20110289497 Kiaie et al. Nov 2011 A1
20110295196 Chazot et al. Dec 2011 A1
20110295341 Estes et al. Dec 2011 A1
20110296051 Vange Dec 2011 A1
20110296411 Tang et al. Dec 2011 A1
20110313789 Karmen et al. Dec 2011 A1
20110319813 Kamen et al. Dec 2011 A1
20110320049 Chossat et al. Dec 2011 A1
20120005680 Dolby et al. Jan 2012 A1
20120011253 Friedman et al. Jan 2012 A1
20120016305 Jollota Jan 2012 A1
20120029941 Malave et al. Feb 2012 A1
20120036102 Fletcher et al. Feb 2012 A1
20120066501 Xiong Mar 2012 A1
20120070045 Vesper et al. Mar 2012 A1
20120095437 Hemmerling Apr 2012 A1
20120112903 Kaib et al. May 2012 A1
20120130198 Beaule May 2012 A1
20120130308 Silkaitis et al. May 2012 A1
20120143116 Ware et al. Jun 2012 A1
20120150556 Galasso et al. Jun 2012 A1
20120157920 Flachbart et al. Jun 2012 A1
20120172802 Blomquist et al. Jul 2012 A1
20120179135 Rinehart et al. Jul 2012 A1
20120179136 Rinehart et al. Jul 2012 A1
20120203177 Lanier Aug 2012 A1
20120245554 Kawamura Sep 2012 A1
20120259978 Petersen et al. Oct 2012 A1
20120277716 Ali et al. Nov 2012 A1
20120283630 Lee et al. Nov 2012 A1
20120284734 McQuaid et al. Nov 2012 A1
20120323212 Murphy Dec 2012 A1
20130006666 Schneider Jan 2013 A1
20130006702 Wu Jan 2013 A1
20130012877 Debelser et al. Jan 2013 A1
20130012879 Debelser et al. Jan 2013 A1
20130012880 Blomquist Jan 2013 A1
20130015980 Evans et al. Jan 2013 A1
20130036403 Geist Feb 2013 A1
20130036412 Birtwhistle et al. Feb 2013 A1
20130066265 Grant Mar 2013 A1
20130072872 Yodfat et al. Mar 2013 A1
20130085689 Sur et al. Apr 2013 A1
20130096444 Condurso et al. Apr 2013 A1
20130096648 Benson Apr 2013 A1
20130102963 Marsh et al. Apr 2013 A1
20130138452 Cork et al. May 2013 A1
20130144206 Lee et al. Jun 2013 A1
20130150824 Estes et al. Jun 2013 A1
20130158504 Ruchti et al. Jun 2013 A1
20130167245 Birtwhistle et al. Jun 2013 A1
20130173473 Birtwhistle et al. Jul 2013 A1
20130191770 Bartz et al. Jul 2013 A1
20130204188 Kamen et al. Aug 2013 A1
20130218080 Peterfreund et al. Aug 2013 A1
20130261993 Ruchti et al. Oct 2013 A1
20130274669 Stempfle et al. Oct 2013 A1
20130275539 Gross et al. Oct 2013 A1
20130291116 Homer Oct 2013 A1
20130296823 Melker et al. Nov 2013 A1
20130296984 Burnett et al. Nov 2013 A1
20130317753 Kamen et al. Nov 2013 A1
20130346108 Kamen et al. Dec 2013 A1
20140025392 Chandrasenan Jan 2014 A1
20140039446 Day Feb 2014 A1
20140163517 Finan et al. Jun 2014 A1
20140180711 Kamen et al. Jun 2014 A1
20140257251 Bush et al. Sep 2014 A1
20140266790 Al-Ali et al. Sep 2014 A1
20140266794 Brown et al. Sep 2014 A1
20140269643 Sun Sep 2014 A1
20140276571 Ludolph Sep 2014 A1
20140288947 Simpson et al. Sep 2014 A1
20140297329 Rock Oct 2014 A1
20140350513 Oruklu et al. Nov 2014 A1
20140358077 Oruklu et al. Dec 2014 A1
20140366878 Baron Dec 2014 A1
20150005935 Bae et al. Jan 2015 A1
20150058044 Butler et al. Feb 2015 A1
20150066531 Jacobson et al. Mar 2015 A1
20150100038 McCann et al. Apr 2015 A1
20150117234 Raman et al. Apr 2015 A1
20150134265 Kohlbrecher et al. May 2015 A1
20150141955 Ruchti et al. May 2015 A1
20150151051 Tsoukalis Jun 2015 A1
20150161354 Blomquist Jun 2015 A1
20150199192 Borges et al. Jul 2015 A1
20150230760 Schneider Aug 2015 A1
20150328396 Adams et al. Nov 2015 A1
20150371004 Jones Dec 2015 A1
20150379237 Mills et al. Dec 2015 A1
20160006695 Prodoehl et al. Jan 2016 A1
20160015885 Pananen et al. Jan 2016 A1
20160034655 Gray et al. Feb 2016 A1
20160045661 Gray et al. Feb 2016 A1
20160051749 Istoc Feb 2016 A1
20160051751 Silkaitis et al. Feb 2016 A1
20160103960 Hume et al. Apr 2016 A1
20160228633 Welsch et al. Aug 2016 A1
20160241391 Fenster Aug 2016 A1
20160285876 Perez et al. Sep 2016 A1
20160350513 Jacobson et al. Dec 2016 A1
20170024534 Arrizza et al. Jan 2017 A1
20170147761 Moskal et al. May 2017 A1
20170246388 Kohlbrecher Aug 2017 A1
20170262590 Karakosta et al. Sep 2017 A1
20170274140 Howard et al. Sep 2017 A1
20170286637 Arrizza et al. Oct 2017 A1
20170319780 Belkin et al. Nov 2017 A1
20170331735 Jha et al. Nov 2017 A1
20180028742 Day et al. Feb 2018 A1
20180043094 Day et al. Feb 2018 A1
20180121613 Connely, IV et al. May 2018 A1
20180181712 Ensey et al. Jun 2018 A1
20180247712 Muhsin et al. Aug 2018 A1
20180322948 Drost et al. Nov 2018 A1
20190006044 Brask Jan 2019 A1
20190096518 Pace Mar 2019 A1
20190132196 Trivedi et al. May 2019 A1
20190147998 Ruchti et al. May 2019 A1
20190228863 Dharwad et al. Jul 2019 A1
20190229982 Ikuta et al. Jul 2019 A1
20190243829 Butler et al. Aug 2019 A1
20190245942 Moskal Aug 2019 A1
20190311803 Kohlbrecher et al. Oct 2019 A1
20190348160 Heavelyn et al. Nov 2019 A1
20190392929 Gassman Dec 2019 A1
20200027541 Xavier et al. Jan 2020 A1
20200027548 Xavier et al. Jan 2020 A1
20200027549 Xavier et al. Jan 2020 A1
20200027550 Xavier et al. Jan 2020 A1
20200027551 Xavier et al. Jan 2020 A1
20200028837 Xavier et al. Jan 2020 A1
20200035355 Xavier et al. Jan 2020 A1
20200054825 Kamen et al. Feb 2020 A1
20200206413 Silkaitis et al. Jul 2020 A1
20200282139 Susi Sep 2020 A1
20200306443 Day Oct 2020 A1
20200330685 Day Oct 2020 A1
20200335194 Jacobson et al. Oct 2020 A1
20200353167 Vivek et al. Nov 2020 A1
20200353168 Keenan et al. Nov 2020 A1
20210043296 Xavier et al. Feb 2021 A1
20210050097 Xavier et al. Feb 2021 A1
20210085855 Belkin et al. Mar 2021 A1
20210098106 Kohlbrecher et al. Apr 2021 A1
20210098107 Xavier et al. Apr 2021 A1
20210105206 Jha et al. Apr 2021 A1
Foreign Referenced Citations (137)
Number Date Country
2 060 151 Aug 1997 CA
2 125 300 Oct 1999 CA
2 898 825 Jul 2014 CA
31 12 762 Jan 1983 DE
34 35 647 Jul 1985 DE
198 44 252 Mar 2000 DE
199 32 147 Jan 2001 DE
103 52 456 Jul 2005 DE
0 319 267 Jun 1989 EP
0 380 061 Aug 1990 EP
0 384 155 Aug 1990 EP
0 460 533 Dec 1991 EP
0 564 127 Jun 1993 EP
0 633 035 Jan 1995 EP
0 652 528 May 1995 EP
0 672 427 Sep 1995 EP
0 683 465 Nov 1995 EP
0 880 936 Dec 1998 EP
1 157 711 Nov 2001 EP
1 174 817 Jan 2002 EP
0 664 102 Apr 2002 EP
1 197 178 Apr 2002 EP
0 830 775 Aug 2002 EP
1 500 025 Apr 2003 EP
2 113 842 Nov 2009 EP
2 228 004 Sep 2010 EP
2 243 506 Oct 2010 EP
2 410 448 Jan 2012 EP
2 742 961 Jun 2014 EP
2 717 919 Sep 1995 FR
2 285 135 Jun 1995 GB
04-161139 Jun 1992 JP
07-502678 Mar 1995 JP
11-500643 Jan 1999 JP
2000-316820 Nov 2000 JP
2002-531154 Sep 2002 JP
2003-016183 Jan 2003 JP
2003-296173 Oct 2003 JP
2005-021463 Jan 2005 JP
2005-527284 Sep 2005 JP
2005-284846 Oct 2005 JP
2006-047319 Feb 2006 JP
2006-520949 Sep 2006 JP
2007-518479 Jul 2007 JP
2007-525256 Sep 2007 JP
2008-080036 Apr 2008 JP
2008-516303 May 2008 JP
2008-158622 Jul 2008 JP
2008-529675 Aug 2008 JP
2009-163534 Jul 2009 JP
2010-502361 Jan 2010 JP
2011-506048 Mar 2011 JP
2012-011204 Jan 2012 JP
2012-070991 Apr 2012 JP
2012-523895 Oct 2012 JP
2014-068283 Apr 2014 JP
WO 84001719 May 1984 WO
WO 91016416 Oct 1991 WO
WO 92010985 Jul 1992 WO
WO 92013322 Aug 1992 WO
WO 94005355 Mar 1994 WO
WO 96008755 Mar 1996 WO
WO 96025186 Aug 1996 WO
WO 98012670 Mar 1998 WO
WO 98019263 May 1998 WO
WO 99051003 Oct 1999 WO
WO 00013580 Mar 2000 WO
WO 00053243 Sep 2000 WO
WO 01014974 Mar 2001 WO
WO 01033484 May 2001 WO
WO 01045014 Jun 2001 WO
WO 02005702 Jan 2002 WO
WO 02036044 May 2002 WO
WO 02049153 Jun 2002 WO
WO 02049279 Jun 2002 WO
WO 02069099 Sep 2002 WO
WO 02081015 Oct 2002 WO
WO 02088875 Nov 2002 WO
WO 03006091 Jan 2003 WO
WO 03050917 Jun 2003 WO
WO 03091836 Nov 2003 WO
WO 03094092 Nov 2003 WO
WO 2004060455 Jul 2004 WO
WO 2004070557 Aug 2004 WO
WO 2004070562 Aug 2004 WO
WO 2004072828 Aug 2004 WO
WO 2005036447 Apr 2005 WO
WO 2005050526 Jun 2005 WO
WO 2005057175 Jun 2005 WO
WO 2005066872 Jul 2005 WO
WO 2007087443 Aug 2007 WO
WO 2007117705 Oct 2007 WO
WO 2007127879 Nov 2007 WO
WO 2007127880 Nov 2007 WO
WO 2008057729 May 2008 WO
WO 2008067245 Jun 2008 WO
WO 2008082854 Jul 2008 WO
WO 2008088490 Jul 2008 WO
WO 2008097316 Aug 2008 WO
WO 2008103915 Aug 2008 WO
WO 2008124478 Oct 2008 WO
WO 2008134146 Nov 2008 WO
WO 2009016504 Feb 2009 WO
WO 2009023406 Feb 2009 WO
WO 2009023407 Feb 2009 WO
WO 2009023634 Feb 2009 WO
WO 2009036327 Mar 2009 WO
WO 2009049252 Apr 2009 WO
WO 2010017279 Feb 2010 WO
WO 2010033919 Mar 2010 WO
WO 2010053703 May 2010 WO
WO 2010075371 Jul 2010 WO
WO 2010099313 Sep 2010 WO
WO 2010114929 Oct 2010 WO
WO 2010119409 Oct 2010 WO
WO 2010124127 Oct 2010 WO
WO 2010130992 Nov 2010 WO
WO 2010135646 Nov 2010 WO
WO 2010135654 Nov 2010 WO
WO 2010135686 Nov 2010 WO
WO 2011005633 Jan 2011 WO
WO 2011022549 Feb 2011 WO
WO 2012048833 Apr 2012 WO
WO 2012049214 Apr 2012 WO
WO 2012049218 Apr 2012 WO
WO 2012120078 Sep 2012 WO
WO 2012140547 Oct 2012 WO
WO 2012164556 Dec 2012 WO
WO 2012170942 Dec 2012 WO
WO 2013045506 Apr 2013 WO
WO 2014100736 Jun 2014 WO
WO 2014131729 Sep 2014 WO
WO 2014131730 Sep 2014 WO
WO 2015124569 Aug 2015 WO
WO 2017176928 Oct 2017 WO
WO 2019219290 Nov 2019 WO
WO 2020227403 Nov 2020 WO
Non-Patent Literature Citations (113)
Entry
Akridge, Jeannie, “New Pumps Outsmart User Error”, Healthcare Purchasing News, Apr. 2011, pp. 10, http://web.archive.org/web/20110426122450/http://www.hpnonline.com/inside/2011-04/1104-OR-Pumps.html.
Alur et al., “Formal Specifications and Analysis of the Computer-Assisted Resuscitation Algorithm (CARA) Infusion Pump Control System”, International Journal on Software Tools for Technology Transfer, Feb. 2004, vol. 5, No. 4, pp. 308-319.
Aragon, Daleen RN, Ph.D., CCRN, “Evaluation of Nursing Work Effort and Perceptions About Blood Glucose Testing in Tight Glycemic Control”, American Journal of Critical Care, Jul. 2006, vol. 15, No. 4, pp. 370-377.
ASHP Advantage, “Improving Medication Safety in Health Systems Through Innovations in Automation Technology”, Proceedings of Educational Symposium and Educational Sessions during the 39th ASHP Midyear Clinical Meeting, Dec. 5-9, 2004, Orlando, FL, pp. 28.
Beard et al., “Total Quality Pain Management: History, Background, Resources”, Abbott Laboratories, TQPM Survey History, available Feb. 2015 or earlier, pp. 1-3.
Bektas et al., “Bluetooth Communication Employing Antenna Diversity”, Proceedings of Eight IEEE International Symposium on Computers and Communication, Jul. 2003, pp. 6.
Bequette, Ph.D., “A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas”, Diabetes Technology & Therapeutics, Feb. 28, 2005, vol. 7, No. 1, pp. 28-47.
Bequette, B. Wayne, Ph.D., “Analysis of Algorithms for Intensive Care Unit Blood Glucose Control”, Journal of Diabetes Science and Technology, Nov. 2007, vol. 1, No. 6, pp. 813-824.
Braun, “Infusomat® Space and Accessories”, Instructions for Use, Nov. 2010, pp. 68. http://corp.bbraun.ee/Extranet/Infusionjipumbad/Kasutusiuhendid/Vanad/Kasutusiuhend-infusomat_Space(vers688J.lnglise_k).pdf.
Brownlee, Seth, “Product Spotlight: The Plum A+ with Hospira MedNet Infusion System”, PP&P Magazine, Dec. 2005, vol. 2, No. 7, pp. 2.
Cannon, MD et al., “Automated Heparin-Delivery System to Control Activated Partial Thromboplastin Time”, Circulation, Feb. 16, 1999, vol. 99, pp. 751-756.
Cardinal Health, “Alaris® Syringe Pumps” Technical Service Manual, Copyright 2002-2006, Issue 9, pp. 1-88, http://www.frankshospitalworkshop.com/equipment/documents/infusion_pumps/service_manuals/Cardinal_Alaris_-_Service_Manual.pdf.
“CareAware® Infusion Management”, Cerner Store, as printed May 12, 2011, pp. 3, https://store.cerner.com/items/7.
Chen et al., “Enabling Location-Based Services on Wireless LANs”, The 11th IEEE International Conference on Networks, ICON 2003, Sep. 28-Oct. 1, 2003, pp. 567-572.
“Computer Dictionary”, Microsoft Press, Third Edition, Microsoft Press, 1997, pp. 430 & 506.
Crawford, Anne J., MSN, RNC, “Building a Successful Quality Pain Service: Using Patient Satisfaction Data and the Clinical Practice Guideline”, USA, 1995, pp. 1-6.
Crocker et al., “Augmented BNF for Syntax Specifications: ABNF”, Network Working Group, Standards Track, Jan. 2008, pp. 16.
Davidson et al., “A Computer-Directed Intravenous Insulin System Shown to be Safe, Simple, and Effective in 120,618 h of Operation”, Diabetes Care, Oct. 2005, vol. 28, No. 10, pp. 2418-2423.
Davies, T., “Cordless Data Acquisition in a Hospital Environment”, IEE Colloquium on Cordless Computing—Systems and User Experience, 1993, pp. 4.
Dayhoff et al., “Medical Data Capture and Display: The Importance of Clinicians' Workstation Design”, AMIA, Inc., 1994, pp. 541-545.
Diabetes Close Up, Close Concerns AACE Inpatient Management Conference Report, Consensus Development Conference on Inpatient Diabetes and Metabolic Control, Washington, D.C., Dec. 14-16, 2003, pp. 1-32.
EAST PhD et al., “Digital Electronic Communication Between ICU Ventilators and Computers and Printers”, Respiratory Care, Sep. 1992, vol. 37, No. 9, pp. 1113-1122.
Einhorn, George W., “Total Quality Pain Management: A Computerized Quality Assessment Tool for Postoperative Pain Management”, Abbott Laboratories, Chicago, IL, Mar. 2, 2000, pp. 1-4.
Eskew et al., “Using Innovative Technologies to Set New Safety Standards for the Infusion of Intravenous Medications”, Hospital Pharmacy, 2002, vol. 37, No. 11, pp. 1179-1189.
Felleiter et al., “Data Processing in Prehospital Emergency Medicine”, International journal of Clinical Monitoring and Computing, Feb. 1995, vol. 12, No. 1, pp. 37-41.
Fogt et al., Development and Evaluation of a Glucose Analyzer for a Glucose-Controlled Insulin Infusion System (Biostator®), Clinical Chemistry, 1978, vol. 24, No. 8, pp. 1366-1372.
Gabel et al., “Camp: A Common API for Measuring Performance”, 21st Large Installations System Administration Conference (LISA '07), 2007, pp. 49-61.
Gage et al., “Automated Anesthesia Surgery Medical Record System”, International Journal of Clinical Monitoring and Computing, Dec. 1990, vol. 7, No. 4, pp. 259-263.
Galt et al., “Personal Digital Assistant-Based Drug Information Sources: Potential to Improve Medication Safety”, Journal of Medical Library Association, Apr. 2005, vol. 93, No. 2, pp. 229-236.
Gardner, Ph.D et al., “Real Time Data Acquisition: Recommendations for the Medical Information Bus (MIB)”, 1992, pp. 813-817.
“General-Purpose Infusion Pumps”, Health Devices, EXRI Institute, Oct. 1, 2002, vol. 31, No. 10, pp. 353-387.
Givens et al., “Exploring the Internal State of User Interfaces by Combining Computer Vision Techniques with Grammatical Inference”, Proceedings of the 2013 International Conference on Software Engineering, San Francisco, CA, May 18-26, 2013, pp. 1165-1168.
Glaeser, “A Hierarchical Minicomputer System for Continuous Post-Surgical Monitoring”, Computers and Biomedical Research, Aug. 31, 1975, pp. 336-361.
Goldberg et al., “Clinical Results of an Updated Insulin Infusion Protocol in Critically III Patients”, Diabetes Spectrum, 2005, vol. 18, No. 3, pp. 188-191.
Gomez et al., “CLAM: Connection-Less, Lightweight, and Multiway Communication Support for Distributed Computing”, Computer Science, 1997, vol. 1199, pp. 227-240.
“GPS Tracker for Medical Equipment”, http://www.trackingsystem.com/forbusinesses/corporate-trackingsystem-1098-gps-tracker-formedicalequipment.html, Mar. 15, 2015, pp. 2.
Graseby, “Model 3000/500 and Micro 3100/505: Volumetric Infusion Pump”, Technical Service Manual, Graseby Medical Ltd., Apr. 2002, Issue A, pp. 160.
Graseby, “Model 3000/500 and Micro 3100/505: Volumetric Infusion Pump: Illustrated Parts List for Pump Serial Numbers from 3000 to 59,999”, Technical Service Manual, Graseby Medical Ltd., Apr. 2002, Issue A, pp. 71.
Halpern et al., “Changes in Critical Care Beds and Occupancy in the United States 1985-2000: Differences Attributable to Hospital Size”, Critical Care Medical, Aug. 2006, vol. 34, No. 8, pp. 2105-2112.
Hamann et al., “Pumpsim: A Software Package for Simulating Computer-Controlled Drug Infusion Pumps”, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1990, vol. 12, No. 5, pp. 2019-2020.
Hasegawa et al., “On a Portable Memory Device for Physical Activities and Informations of Maternal Perception”, Journal of Perinatal Medicine, 1988, vol. 16, No. 4, pp. 349-356.
Hawley et al., “Clinical Implementation of an Automated Medical Information Bus in an Intensive Care Unit”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 9, 1988, pp. 621-624.
Hayes-Roth et al., “Guardian: A Prototype Intelligent Agent for Intensive-Care Monitoring”, Artificial Intelligence in Medicine, vol. 4, Dec. 31, 1992, pp. 165-185.
Hospira, GemStar® Pain Management Infusion System 9-084-PR1-2-2, www.hospira.com/products/gemstar_painmanagement.aspx, Jan. 28, 2010, pp. 1-2.
Introducing Abbott TQPM (Total Quality Pain Management), Abbott Laboratories, Abbott Park, IL, May 2000, pp. 1-4.
“Infusion Pump”, Wikipedia.org, as last modified Mar. 27, 2014, in 3 pages, https://web.archive.org/web/20140703024932/https://en.wikipedia.org/wiki/infusion_pump.
Isaka et al., “Control Strategies for Arterial Blood Pressure Regulation”, IEEE Transactions on Biomedical Engineering, Apr. 1993, vol. 40, No. 4, pp. 353-363.
Johnson et al., “Using BCMA Software to Improve Patient Safety In Veterans Administration Medical Centers”, Journal of Healthcare Information Management, Dec. 6, 2004, vol. 16, No. 1, pp. 46-51.
Kent Displays, “Reflex ™ Electronic Skins”, Product Brief 25127B, 2009, pp. 2.
Kent Displays, “Reflex Electronic Skins Engineering Evaluation Kit”, 25136A, Mar. 10, 2009.
Lefkowitz et al., “A Trial of the Use of Bar Code Technology to Restructure a Drug Distribution and Administration System”, Hospital Pharmacy, Mar. 31, 1991, vol. 26, No. 3, pp. 239-242.
Lenssen et al., “Bright Color Electronic Paper Technology and Applications”, IDS '09 Publication EP1-2 (Phillips Research), 2009, pp. 529-532.
Leveson, Nancy, “Medical Devices: The Therac-25”, Appendix A, University of Washington, 1995, pp. 49.
Linkens, D.A. “Computer Control for Patient Care”, Computer Control of Real-Time Processes, IEE Control Engineering Series 41, 1990, Ch. 13, pp. 216-238.
Mako Hill et al., “The Official Ubuntu Book”, Shoeisha Co., Ltd., 1st Edition, Jun. 11, 2007, pp. 115 to 125.
Marshall, et al., “New Microprocessor-Based Insulin Controller”, IEEE Transactions on Biomedical Engineering, Nov. 1983, vol. BME-30, No. 11, pp. 689-695.
Martino et al., “Automation of a Medical Intensive Care Environment with a Flexible Configuration of Computer Systems”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 5, 1980, vol. 3, pp. 1562-1568.
Matsunaga et al., “On the Use of Machine Learning to Predict the Time and Resources Consumed by Applications”, 2010 10th IEEE/ACM International Conference on Cluster, Cloud and Grid Computing (CCGrid), May 17-20, 2010, pp. 495-504.
Mauseth et al., “Proposed Clinical Application for Tuning Fuzzy Logic Controller of Artificial Pancreas Utilizing a Personalization Factor”, Journal of Diabetes Science and Technology, Jul. 2010, vol. 4, No. 4, pp. 913-922.
Medfusion™, “Medfusion Syringe Infusion Pump Model 4000”, Operator's Manual, Software Version V1.1, Sep. 2011, pp. 154. http://www.medfusionpump.com/assets/literature/manuals/Operators_Manual_4000_40-5760-51A.pdf.
Metnitz et al., “Computer Assisted Data Analysis in Intensive Care: the ICDEV Project-Development of a Scientific Database System for Intensive Care”, International Journal of Clinical Monitoring and Computing, Aug. 1995, vol. 12, No. 3, pp. 147-159.
Micrel Medical Devices, “MP Daily—” http://web.archive.org/web/20130803235715/http://www.micrelmed.com/index.aspx?productid=9 archived Aug. 3, 2013 in 1 page.
Moghissi, Etie, MD, FACP, FACE, “Hyperglycemia in Hospitalized Patients”, A Supplement to AGP Hospitalist, Jun. 15, 2008, pp. 32.
Murray, Jr. et al., “Automated Drug Identification System (during surgery)”, IEEE Proceedings of Southeastcon '91, Apr. 7-10, 1991, pp. 265.
Nicholson et al., “‘Smart’ Infusion Apparatus for Computation and Automated Delivery of Loading, Tapering, and Maintenance Infusion Regimens of Lidocaine, Procainamide, and Theophylline”, Proceedings of The Seventh Annual Symposium on Computer Applications in Medical Care, Oct. 1983, pp. 212-213.
Nolan et al., “The P1073 Medical Information Bus Standard: Overview and Benefits for Clinical Users”, 1990, pp. 216-219.
Omnilink Systems, Inc., “Portable Medical Equipment Tracking”, http://www.omnilink.com/portablemedicalequipmenttracking/ Mar. 15, 2015, pp. 2.
O'Shea, Kristen L., “Infusion Management: Working Smarter, Not Harder”, Hospital Pharmacy, Apr. 2013, vol. 48, No. 3, pp. S1-S14.
Package Management in Debian GNU/Linux, Debian GNU/Linux Expert Desktop Use Special, Giutsu-Hyohron Co., Ltd., First Edition, Sep. 25, 2004, pp. 183-185.
Passos et al., “Distributed Software Platform for Automation and Control of General Anaesthesia”, Eighth International Symposium on Parallel and Distributed Computing, ISPDC '09, Jun. 30-Jul. 4, 2009, pp. 8.
Philips, “IntelliSpace Event Management and IntelliVue Patient Monitoring”, Release 10, 2011, http://incenter.medical.phillips.com/doclib/enc/fetch/2000/4504/577242/577243/577247/582646/583147/8359175/Phillips_Patient_Monitoring_and_IntelliSpace_Event_Management_Interoperability.pdf%2fnodeid53d8508574%26vernum53d-2, pp. 2.
Pretty et al., “Hypoglycemia Detection in Critical Care Using Continuous Glucose Monitors: An in Silico Proof of Concept Analysis”, Journal of Diabetes Science and Technology, Jan. 2010, vol. 4, No. 1, pp. 15-24.
Rappoport, Arthur E., “A Hospital Patient and Laboratory Machine-Readable Identification System (MRIS) Revisited”, Journal of Medical Systems, Apr. 1984, vol. 8, Nos. 1/2, pp. 133-156.
Ritchie et al., “A Microcomputer Based Controller for Neuromuscular Block During Surgery”, Annals of Biomedical Engineering, Jan. 1985, vol. 13, No. 1, pp. 3-15.
Saager et al., “Computer-Guided Versus Standard Protocol for Insulin Administration in Diabetic Patients Undergoing Cardiac Surgery”, Annual Meeting of the American Society of Critical Care Anesthesiologists, Oct. 13, 2006.
Sanders et al., “The Computer in a Programmable Implantable Medication System (PIMS)”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 2, 1982, pp. 682-685.
Schilling et al., “Optimizing Outcomes! Error Prevention and Evidence-Based Practice with IV Medications”, A Pro-Ce Publication, Hospira, Inc., Feb. 6, 2012, pp. 56.
Schulze et al., “Advanced Sensors Technology Survey”, Final Report, Feb. 10, 1992, pp. 161.
Scott, et al., “Using Bar-Code Technology to Capture Clinical Intervention Data in a Hospital with a Stand-Alone Pharmacy Computer System”, Mar. 15, 1996, American Journal of Health-System Pharmacy, vol. 53, No. 6, pp. 651-654.
Sebald et al., “Numerical Analysis of a Comprehensive in Silico Subcutaneous Insulin Absorption Compartmental Model”, 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Sep. 2-6, 2009, pp. 3901-3904.
Shabot, M. Michael, “Standardized Acquisition of Bedside Data: The IEEE P1073 Medical Information Bus”, International Journal of Clinical Monitoring and Computing, vol. 6, Sep. 27, 1989, pp. 197-204.
Sheppard, Louis, Ph.D., “Automation of the Infusion of Drugs Using Feedback Control”, Journal of Cardiothoracic and Vascular Anesthesia, Feb. 28, 1989, vol. 3, No. 1, pp. 1-3.
Sheppard, Louis, Ph.D., “Computer Control of the Infusion of Vasoactive Drugs”, Annals of Biomedical Engineering, Jul. 1980, vol. 8, No. 4-6, pp. 431-444.
Sheppard, Louis, Ph.D., “The Application of Computers to the Measurement, Analysis, and Treatment of Patients Following Cardiac Surgical Procedures”, The University of Alabama in Birmingham, Oct. 31, 1977, pp. 297-300.
Sheppard, Louis, Ph.D., “The Computer in the Care of Critically III Patients”, Proceedings of the IEEE, Sep. 1979, vol. 67, No. 9, pp. 1300-1306.
“Sigma Spectrum: Operator's Manual”, Oct. 2009, pp. 72. https://static.medonecapital.com/manuals/userManuals/Sigma-Spectrum-Operator-Manual-October-2009.pdf.
Simonsen, Michael Ph.D., POC Testing, New Monitoring Strategies on Fast Growth Paths in European Healthcare Arenas, Biomedical Business & Technology, Jan. 2007, vol. 30, No. 1, pp. 1-36.
Siv-Lee et al., “Implementation of Wireless ‘Intelligent’ Pump IV Infusion Technology in a Not-for-Profit Academic Hospital Setting”, Hospital Pharmacy, Sep. 2007, vol. 42, No. 9, pp. 832-840. http://www.thomasland.com/hpl4209-832.pdf.
Slack, W.V., “Information Technologies for Transforming Health Care”, https://www.andrew.cmu.edu/course/90-853/medis.dir/otadocs.dir/03ch2.pdf, Ch. 2, 1995, pp. 29-78.
Smith, Joe, “Infusion Pump Informatics”, CatalyzeCare: Transforming Healthcare, as printed May 12, 2011, pp. 2.
Sodders, Lisa, “VA Center Keeps Medicine in Right Hands”, The Capital-Journal, Dec. 4, 1999, pp. 1-2.
Stitt, F.W., “The Problem-Oriented Medical Synopsis: a Patient-Centered Clinical Information System”, Proceedings of the Annual Symposium on Computer Application in Medical Care, 1994, pp. 88-92.
Stokowski, Laura A. RN, MS, “Using Technology to Improve Medication Safety in the Newborn Intensive Care Unit”, Advances in Neonatal Care, Dec. 2001, vol. 1, No. 2, pp. 70-83.
Sutton et al., “The Syntax and Semantics of the PROforma Guideline Modeling Language”, Journal of the American Medical Informatics Association, Sep./Oct. 2003, vol. 10, No. 5, pp. 433-443.
Szeinbach et al., “Automated Dispensing Technologies: Effect on Managed Care”, Journal of Managed Care Pharmacy (JMCP), Sep./Oct. 1995, vol. 1, No. 2, pp. 121-127.
Szolovits et al., “Guardian Angel: Patient-Centered Health Information Systems”, Technical Report MIT/LCS/TR-604, Massachusetts Institute of Technology Laboratory for Computer Science, May 1994, pp. 39.
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in Critically III Patients”, The New England Journal of Medicine, Nov. 8, 2001, vol. 345, No. 19, pp. 1359-1367.
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in the Medical ICU”, The New England Journal of Medicine, Feb. 2, 2006, vol. 354, No. 5, pp. 449-461.
Van Der Maas et al., “Requirements for Medical Modeling Languages”, Journal of the American Medical Informatics Association, Mar./Apr. 2001, vol. 8, No. 2, pp. 146-162.
Villalobos et al., “Computerized System in Intensive Care medicine”, Medical Informatics, vol. 11, No. 3, 1986, pp. 269-275.
Wilkins et al., “A Regular Language: The Annotated Case Report Form”, PPD Inc., PharmaSUG2011—Paper CD18, 2011, pp. 1-9.
Ying et al., “Regulating Mean Arterial Pressure in Postsurgical Cardiac Patients. A Fuzzy Logic System to Control Administration of Sodium Nitroprusside”, IEEE Engineering in Medicine and Biology Magazine, vol. 13, No. 5, Nov.-Dec. 1994, pp. 671-677.
Yue, Ying Kwan, “A Healthcare Failure Mode and Effect Analysis on the Safety of Secondary Infusions”, Thesis, Institute of Biomaterials and Biomedical Engineering, University of Toronto, 2012, pp. 168.
Yurkonis et al., “Computer Simulation of Adaptive Drug Infusion”, IEEE Transactions on Biomedical Engineering, vol. BME-34, No. 8, Aug. 1987, pp. 633-635.
Zakariah et al., “Combination of Biphasic Transmittance Waveform with Blood Procalcitonin Levels for Diagnosis of Sepsis in Acutely III Patients”, Critical Care Medicine, 2008, vol. 36, No. 5, pp. 1507-1512.
International Search Report and Written Opinion received in PCT Application No. PCT/US2010/031351, dated Jun. 28, 2010 in 9 pages.
International Preliminary Report on Patentability and Written Opinion received in PCT Application No. PCT/US2010/031351, dated Oct. 27, 2011 in 8 pages.
“Context-Free Grammar”, Wikipedia.org, as last modified Mar. 5, 2010 in 11 pages, https://wikipedia.org/w/index.php/?title=Context-free_grammar&oldid=347915989.
“Download”, Free On-Line Dictionary of Computing, as archived Jun. 16, 2010 in 1 page, https://web.archive.org/web/201006106010314/https://foldoc.org/download.
Edworthy, Judy, “Medical Audible Alarms: A Review”, Journal of the American Medical Informatics Association, vol. 20, No. 3, 2013, pp. 584-589.
“File Verification”, Wikipedia.org, as last modified Oct. 11, 2011 in 2 pages, https://en.wikipedia.org/w/index/php?title=File_verification&oldid=455048290.
“McKesson Automation and ALARIS Medical Systems Developing Point-of-Care Bar Coding Solution to Improve IV Medication Safety”, PR Newswire, NY, Dec. 9, 2002, pp. 4.
“Software Versioning”, Wikipedia.org, dated Oct. 16, 2011 in 11 pages, https://en.wikipedia.org/w/index.php?title=Software_versioning&oldid=455859110.
Related Publications (1)
Number Date Country
20210316072 A1 Oct 2021 US
Provisional Applications (1)
Number Date Country
61170205 Apr 2009 US
Divisions (1)
Number Date Country
Parent 12761107 Apr 2010 US
Child 13586615 US
Continuations (3)
Number Date Country
Parent 16266622 Feb 2019 US
Child 17238780 US
Parent 15467903 Mar 2017 US
Child 16266622 US
Parent 13586615 Aug 2012 US
Child 15467903 US